EurekaMag Full Text Articles Chapter 72,759

Wilkins, R.W. 1957: The treatment of hypertension. Clinical Symposia 9(4): 115-133

Rosnick, M.J. 1961: The treatment of hypertension. Medical Times 89: 1330-1333

Hayden, J.G. 1952: The treatment of hypertension. Medical Journal of Australia 1(20): 682-684

East, T. 1948: The treatment of hypertension. Modern Treatment Yearbook 1: 1-8

East, T. 1947: The treatment of hypertension. Medical Press 218(17): 366-369

Eppinga, P.; Leemhuis, M.P. 1985: The treatment of hypertension in patients with diabetes mellitus. Nederlands Tijdschrift Voor Geneeskunde 129(46): 2195-2199

Milliez, J.; Plouin, P.F.; Sureau, C. 1982: The treatment of hypertension in pregnancy. Therapie 37(2): 171-179

Borghi, C.; Esposti, D.D.; Cassani, A.; Immordino, V.; Bovicelli, L.; Ambrosioni, E. 2002: The treatment of hypertension in pregnancy. Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 20(2): S52-S56

Moyer, J.H. 1958: The treatment of hypertensive emergencies. Minnesota Medicine 41(5): 301-316

Haugen, H.N. 1973: The treatment of hyperthyroidism. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 93(27): 2050-2052

Bansi, H.W. 1953: The treatment of hyperthyroidism. Therapie der Gegenwart 92(4): 121-125

Goldsmith, R. 1960: The treatment of hyperthyroidism. Journal-Lancet 80: 271-275

Studer, H.; Koenig, M.P. 1963: The treatment of hyperthyroidism. Revue Medicale de la Suisse Romande 83: 228-237

Bricaire, H. 1963: The treatment of hyperthyroidism. La Revue du Praticien 13: 2363-2376

Cole, W.H. 1947: The treatment of hyperthyroidism. Mississippi Doctor 25(3): 93-100

Pietra, R. 1948: The treatment of hyperthyroidism with aminothiazole. Minerva Medica 39(34 Part 2): 173-176

Bell, R.L. 1974: The treatment of hyperthyroidism with radioactive iodine. Journal of the Tennessee Medical Association 67(7): 568-570

Francke, G.; Robert, W.N. 1968: The treatment of hyperthyroidism with radioactive iodine. Nederlands Tijdschrift Voor Geneeskunde 112(48): 2181-2184

Nicholson, W.M.; Garrett, N.H.; Bishopric, G.A. 1954: The treatment of hyperthyroidism with radioactive iodine. North Carolina Medical Journal 15(11): 544-548

Maloof, F. 1955: The treatment of hyperthyroidism with radioactive iodine. BULLETIN. Tufts-New England Medical Center 1(4): 219-223

Barambon, D. 1961: The treatment of hyperthyroidism with radioactive iodine. Praxis 50: 775-781

Cornelissen, E.A.M.; Knoers, N.V.A.M. 2002: The treatment of hypomagnesemia. Nederlands Tijdschrift Voor Geneeskunde 146(49): 2387; Author Reply 2387-8

Naef, A.P. 1947: The treatment of hypoproteinemia in surgical pathology. Helvetica Chirurgica Acta 14(2): 88-101

Smith, D.R. 1953: The treatment of hypospadias. California Medicine 78(2): 95-100

Pilcher, F. 1955: The treatment of hypospadias. Canadian Medical Association Journal 72(3): 195-199

Creevy, C.D. 1958: The treatment of hypospadias. Minnesota Medicine 41(8): 563-568 Passim

Lipworth, E. 1952: The treatment of hypospadias. South African Medical Journal 26(22): 453-455

Freebourn, T.M.; Barber, D.B.; Able, A.C. 1999: The treatment of immature heterotopic ossification in spinal cord injury with combination surgery, radiation therapy and NSAID. Spinal Cord 37(1): 50-53

Fox, P.B. 1951: The treatment of impetigo. Practitioner 166(992): 189-192

Cernea, R. 1948: The treatment of impotence in humans. Ars Medici; Revue Internationale Pour le Medecin Praticien 3(9): 658-662

Smith, I. 1981: The treatment of inborn errors of the urea cycle. Nature 291(5814): 378-380

Collins, J.H. 1951: The treatment of incomplete abortion. Bulletin of the Tulane Medical Faculty 10(3): 135-137

Andrade, B. 1946: The treatment of infantile nephropathies; Knowledge of renal pathophysiology, the scientific basis of treatment. Pediatria de Las Americas 4: 193-210

Lewin, P. 1948: The treatment of infantile paralysis during the acute stage. Journal of the Indiana State Medical Association 41(9): 908-910

Boulin, R.; Uhry, P.; Pierard 1947: The treatment of infectious complications of diabetes mellitus with penicillin. Gazette Medicale de France 54(24): 803

Resál, T.ás.; Rutka, M.; Szántó, K.; Farkas, K.; Molnár, T.ás. 2020: The treatment of inflammatory bowel disease during the SARS-CoV-2 epidemic – practical advices: (A COVID–19-pandémia orvosszakmai kérdései). Orvosi Hetilap 161(25): 1022-1027

Stonham, F.V. 1946: The treatment of inguinal hernia. Medical Journal of Australia 1: 185-187

Vene, M.L.; Mascitelli, E.; Rea, T.; Tauro, A.; Picardi, N. 2003: The treatment of inguinal hernia: experience of a Operative Surgery Unit. Annali Italiani di Chirurgia 74(2): 159-163

Martin, J. 1947: The treatment of injuries of the spinal cord. Arizona Medicine 4(4): 28-31

Martin, J. 1947: The treatment of injuries of the spinal cord. Surgery Gynecology and Obstetrics 84(5): 403-416

Orr, L.M.; Campbell, J.L.; Thomley, M.W. 1954: The treatment of inoperable prostatic carcinoma with au 198. American Surgeon 20(10): 1110-1118

Hamilton, M.; Wilson, G.M. 1952: The treatment of intermittent claudication. Quarterly Journal of Medicine 21(82): 169-183

Zhu, L.; Yu, C.; Zhang, X.; Yu, Z.; Zhan, F.; Yu, X.; Wang, S.; He, F.; Han, Y.; Zhao, H. 2020: The treatment of intervertebral disc degeneration using Traditional Chinese Medicine. Journal of Ethnopharmacology 263:: 113117

Brown, C.A.; Kell, J.F. 1955: The treatment of intractable pain. JOURNAL. Iowa State Medical Society 45(1): 4-8

Richardson, J.S. 1958: The treatment of intractable pain. South African Medical Journal 32(6): 158-162

Stubbs, D.; Murphy, J.P. 1947: The treatment of intractable pain. New York State Journal of Medicine 47(19): 2094-2097

Ward, B.; Mather, S.; Shepherd, J.; Crowther, M.; Hawkins, L.; Britton, K.; Slevin, M.L. 1988: The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy. British Journal of Cancer 58(5): 658-662

Tavernier, L. 1946: The treatment of inverted congenital dislocations of the hip; the place of joint ventilation in this treatment. Revue d'Orthopedie et de Chirurgie de l'Appareil Moteur 32(3-4): 109-116

Reese, A.B.; Cleasby, G.W. 1959: The treatment of iris melanoma. Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology 63(3): 296-304; Discussion: 304-305

Belisario, J.C. 1957: The treatment of keloids. Acta Dermato-Venereologica 37(2): 165-181

Branchi, P.P. 1948: The treatment of labyrinthine angio-neuroses with vitamins PP and B2. RivistaOto-Neuro-Oftalmologica 23(4): 305

Garin, C. 1949: The treatment of large taenias and bothrioccephalus. Journal de Medecine de Lyon 30(703): 299-301

LeLOURD, R. 1945: The treatment of laryngeal tuberculosis by infiltration of the carotid sinuses. La Presse Medicale 53: 503

Le LOURD 1945: The treatment of laryngeal tuberculosis by infiltration of the carotid sinuses. Revue de la Tuberculose 9(10): 208-211

Degos, R. 1968: The treatment of leprosy. Dermatologia Internationalis 7(2): 81-83

Malaguti, A. 1948: The treatment of leptospirosis with penicillin; description of a case. Il Progresso Medico 5(15): 468-473

Coleman, W.A.; Swisher, S.N. 1955: The treatment of leukemia. Gp 12(2): 97-104

Reisner, E.H. 1957: The treatment of leukemia. Medical Times 85(3): 239-245

Frei, E. 1958: The treatment of leukemia. Journal of the National Medical Association 50(5): 358-360

Frei, E. 1958: The treatment of leukemia. Gp 18(5): 98-100

Miller, F.R. 1947: The treatment of leukemia. Pennsylvania Medical Journal 50(12): 1331-1333

DeLOR, C.J. 1949: The treatment of liver disease. Health Center Journal 2(3): 109-113

De Bruyne, J.I. 1949: The treatment of lues congenita with penicillin. Nederlands Tijdschrift Voor Geneeskunde 93(18): 1459

Denes, I. 1961: The treatment of lumbago in general practice. Orvosi Hetilap 102: 1276-1277

Morrison, D.R. 1951: The treatment of lung abscess. Connecticut State Medical Journal 15(7): 581-583

Dussek, J.E. 1991: The treatment of lung cancer. British Journal of Clinical Practice 45(3): 176-177

Sluiter, H.J. 1982: The treatment of lung cancer. Nederlands Tijdschrift Voor Geneeskunde 126(20): 913-915

Steinberg, A.D. 1986: The treatment of lupus nephritis. Kidney International 30(5): 769-787

Fontana, F.; Alfano, G.; Cappelli, G. 2021: The treatment of lupus nephritis, between consolidated strategies and new therapeutic options: a narrative review. Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 38(4)

Miller, F.R.; Jones, H.W.; Herbut, P.A. 1947: The treatment of lymphoblastic leukemia with crude myelokentric acid. Transactions and Studies of the College of Physicians of Philadelphia 15(1): 42

Andersen, B.J.; Brøchner-Mortensen, K. 1948: The treatment of lymphogranulomatosis with nitrogen mustard gas. Nordisk Medicin 37(2): 87

Lagrot, F. 1948: The treatment of major burns. Maroc Medical 27(275): 158-165

Cowie, R.L. 1978: The treatment of malaria. South African Medical Journal 54(10): 383

Gear, J.H.; Fripp, P.J.; Cassel, R.; Miller, B. 1978: The treatment of malaria. South African Medical Journal 53(23): 921

O'Brien, W. 1975: The treatment of malaria. Practitioner 215(1288): 487-492

Kager, P.A. 1992: The treatment of malaria. Nederlands Tijdschrift Voor Geneeskunde 136(40): 1965-1968

Powell, R.D. 1972: The treatment of malaria. Rational Drug Therapy 6(4): 1-6

Overbosch, D.; Stuiver, P.C.; van der Kaay, H.J.; de Geus, A. 1984: The treatment of malaria. Nederlands Tijdschrift Voor Geneeskunde 128(50): 2360-2364

Kager, P.A.; Zijlmans, C.W.; Boele van Hensbroek, M.; Wetsteyn, J.C. 1997: The treatment of malaria. Nederlands Tijdschrift Voor Geneeskunde 141(37): 1774-1778

Everard Napier, L. 1951: The treatment of malaria. Medical Press 225(10): 229-232

Saunders, G.M. 1947: The treatment of malaria. Missouri Medicine 44(2): 89-94

Hardgrove, M.; Brown, J.B. 1947: The treatment of malaria. Wisconsin Medical Journal 46(4): 420-422

Blackburn, C.R.B. 1946: The treatment of malaria. Bulletin of the Post-Graduate Committee in Medicine University of Sydney 2(7): 183-189

Hamid, R.; Arya, M.; Khastgir, J.; Patel, H.R.H.; Shah, P.J.R. 2003: The treatment of male stress urinary incontinence with polydimethylsiloxane in compliant bladders following spinal cord injury. Spinal Cord 41(5): 286-289

Warthen, H.J. 1949: The treatment of malignant melanoma. Virginia Medical Monthly 76(10): 528-531

Windeyer, B.W. 1960: The treatment of malignant melanoma of the skin. Strahlentherapie Suppl 46: 36-42

Salhia, B.; Rutka, J.T.; Lingwood, C.; Nutikka, A.; Van Furth, W.R. 2002: The treatment of malignant meningioma with verotoxin. Neoplasia 4(4): 304-311

Darget, R. 1947: The treatment of malignant tumors of the bladder by the open bladder implantation of radium needles. MEMOIRES. Academie de Chirurgie 73(25 26): 529

Reading, A.; Raw, M. 1976: The treatment of mandibular dysfunction pain. Possible application of psychological methods. British Dental Journal 140(6): 201-205

Diamond, J.L. 1946: The treatment of medical jaundice. Minnesota Medicine 29: 684-688

Gautier, P. 1948: The treatment of meningitis in infants and children. Revue Medicale de la Suisse Romande 68(12): 797-809

Smith, H.V. 1947: The treatment of meningitis with penicillin. Revue Neurologique (Paris) 79(4): 243-245

Wang, Y-P.; Yu, Q. 2020: The treatment of menopausal symptoms by traditional Chinese medicine in Asian countries. Climacteric: the Journal of the International Menopause Society 2020: 1-4

Sica, S.; Sorà, F.; Laurenti, L.; Chiusolo, P.; Piccirillo, N.; Scirpa, P.; Leone, G. 2005: The treatment of menorrhagia in female stem cell transplant recipients. Bone Marrow Transplantation 35(8): 827

Lambert, J.E.; Nantogmah, F.; Dokurugu, A.Y.; Alhassan, H.; Azuure, S.S.; Yaro, P.B.; Kørner, J. 2020: The treatment of mental illness in faith-based and traditional healing centres in Ghana: perspectives of service users and healers. Global Mental Health 7: E28

Cooper, P. 1971: The treatment of migraine. Midwife and Health Visitor 7(6): 237

Badalian, L.O.; Temin, P.A.; Nikanorova, M.I. 1995: The treatment of migraine. Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 95(4): 87-93

Titus, F. 1997: The treatment of migraine. Revista de Neurologia 25(138): 295-300

Barbizet, J. 1954: The treatment of migraine. Concours Medical 76(27): 2717-2724

Crosby, R.C. 1956: The treatment of migraine. Arizona Medicine 13(2): 41-48

Casanova, P. 1962: The treatment of migraine. Marseille Medical 99: 503-507

Dejong, R.N. 1962: The treatment of migraine. American Journal of Nursing 62: 67-71

Podolsky, E. 1949: The treatment of migraine. Medical Record 162(5): 11

Li, F.N.; Li, Z.H.; Huang, X.; Yu, S.Z.; Zhang, F.; Chen, Z.; Shen, H.X.; Cai, B.; Hou, T.S. 2014: The treatment of mild cervical spondylotic myelopathy with increased signal intensity on T2-weighted magnetic resonance imaging. Spinal Cord 52(5): 348-353

Cammertoni, F.; Bruno, P.; Mazza, A.; Massetti, M. 2020: The treatment of mitral insufficiency in refractory heart failure. European Heart Journal Suppls: Journal of the European Society of Cardiology 22(Suppl L): L93-L96

Noble, R.L.; Sellers, E.A.; Best, C.H. 1947: The treatment of motion sickness. Canadian Medical Association Journal 56(4): 417-424

Pick, A.I.; Schoenfeld 1974: The treatment of multiple myeloma. Harefuah 86(11): 558-560

Ludwig, H.; Kührer, I. 1994: The treatment of multiple myeloma. Wiener Klinische Wochenschrift 106(14): 448-454

Johnson, P.W.; Selby, P.J. 1994: The treatment of multiple myeloma--an important MRC trial. British Journal of Cancer 70(5): 781-785

Putnam, T.J. 1950: The treatment of multiple sclerosis. Research Publications - Association for Research in Nervous and Mental Disease 28: 585-594

Michon, P.; Heully, F.; Cayotte, J. 1948: The treatment of multiple sclerosis. Revue Medicale de Nancy 73(1-15): 334-336

Magee, K.R. 1959: The treatment of myasthenia gravis. Gp 19(6): 117-126

Walker, M. 1946: The treatment of myasthenia gravis. Medical Press 216: 81-84

Birenbaum, R.F. 1980: The treatment of mycosis fungoides. Harefuah 98(7): 308-311

Mestel, D.S.; Beyer, M.; Steinhoff, M.; Sterry, W.; Assaf, C. 2008: The treatment of mycosis fungoides. Giornale Italiano di Dermatologia e Venereologia: Organo Ufficiale Societa Italiana di Dermatologia e Sifilografia 143(6): 395-408

Freehafer, A.A. 1974: The treatment of myelomeningocele patients with paralytic hip deformities by iliopsoas transfer. Paraplegia 11(4): 295-305

Bakker, S.; Zuydam, D.M. 1948: The treatment of neck fistulas in horses with penicillin. TijdschriftVoorDiergeneeskunde 73(17-18): 690

Laroche, C. 1948: The treatment of nephritis; action of antibiotics. Bulletin Medical 62(8): 113-116

Thomson, W.A. 1960: The treatment of nephrosis. El Dia Medico 32: 2129-2131

Wardley, A.M.; Jayson, G.C.; Goldsmith, D.J.; Venning, M.C.; Ackrill, P.; Scarffe, J.H. 1998: The treatment of nephrotic syndrome caused by primary (light chain) amyloid with vincristine, doxorubicin and dexamethasone. British Journal of Cancer 78(6): 774-776

D'heucqueville, G.; Ducros, J. 1947: The treatment of neuritis in children. Archives Internationales de Neurologie des Maladies Hereditaires de Medecine Mentale et Psychosomatique 66(4): 88

Godlewski, S. 1949: The treatment of neuroanemic syndromes with vitamin B12. Paris Medical 2(5): 136-138

Trbovich, M.; Romo, T.; Polk, M.; Koek, W.; Kelly, C.; Stowe, S.; Kraus, S.; Kellogg, D. 2021: The treatment of neurogenic lower urinary tract dysfunction in persons with spinal cord injury: An open label, pilot study of anticholinergic agent vs. mirabegron to evaluate cognitive impact and efficacy. Spinal Cord Series and Cases 7(1): 50

Susman, E. 1949: The treatment of neurosyphilis. Medical Journal of Australia 2(24): 829-831

Hilliard, E.T. 1949: The treatment of neurosyphilis. Medical Journal of Australia 2(24): 831-834

Martin, J.P. 1949: The treatment of neurosyphilis. Practitioner 162(971): 361-368

Cox, L.B. 1949: The treatment of neurosyphilis. Medical Journal of Australia 1(14): 449-451

Adams, R.D. 1948: The treatment of neurosyphilis. Connecticut State Medical Journal 12(9): 832-838

Nicole, J.E. 1947: The treatment of neurosyphilis. Medical Press 218(20): 439-442

Ferroir, J. 1949: The treatment of obese. L' Hopital 37(577): 166-170

Penick, S.B.; Stunkard, A.J. 1972: The treatment of obesity. Advances in Psychosomatic Medicine 7: 217-228

Lebon, P. 1967: The treatment of obesity. District Nursing 9(12): 286-288

Klotz, H.P. 1965: The treatment of obesity. Semaine Therapeutique 41(2): 74-76

Humplik, H. 1966: The treatment of obesity. Minerva Medica 57(103): 4486-4492

Lebrun, H. 1983: The treatment of obesity. Nursing Quebec 4(1): 12-17

Stumpf, D. 1984: The treatment of obesity. South African Medical Journal 65(1): 4

Mina, W.C.; Burns, R.W.; Terry, B.E. 2003: The treatment of obesity. Missouri Medicine 100(3): 248-255

Becker, S.F. 1953: The treatment of obesity. Journal of the American Medical Women's Association 8(6): 191-194

Spiegl, F.V. 1954: The treatment of obesity. Medizinische Klinik 49(22): 888-890

Bel, A. 1962: The treatment of obesity. Journal de Medecine de Lyon 43: 1341-1351

Seaton, D.A.; Duncan, L.J. 1963: The treatment of obesity. British Journal of Clinical Practice 17: 137-140

Martel, A. 1959: The treatment of obesity. Laval Medical 28: 640-642

Lewis, A.A. 1950: The treatment of obesity. Nursing Mirror and Midwives Journal 92(2382): 131-132

Hales, H. 1946: The treatment of obesity. Punjab Medical Journal 11(9): 198-202

Pfister, C. 1949: The treatment of obesity with benzene. Revue Medicale de la Suisse Romande 69(5): 288-293

Kuhlmann, J.; Le Maistre, D. 1949: The treatment of oblique humeral and tibial fractures by medullary nailing. Strasbourg Medical 109(6): 67-71

Karrer, W. 1994: The treatment of obstructive sleep apnea. Praxis 83(49): 1383-1387

Bedrossian, R.H. 1968: The treatment of ocular inflammation with hydroxymesterone. Transactions of the Pacific Coast Oto-Ophthalmological Society Annual Meeting 52: 185-195

Roper-Hall, M.J. 1959: The treatment of ocular injuries. Transactions of the Ophthalmological Societies of the United Kingdom 79: 57-69

Volkmann, J. 1948: The treatment of old tubercular and osteomyelitic fistulas of the hip joint. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 19(4): 160-162

Bosio, U.; Bardini, T. 1962: The treatment of omphalocele. Minerva Medica 53: 3967-3971

Girvan, D.P.; Webster, D.M.; Shandling, B. 1974: The treatment of omphalocele and gastroschisis. Surgery Gynecology and Obstetrics 139(2): 222-224

Junet, W. 1947: The treatment of open and closed cranio-cerebral trauma. Helvetica Chirurgica Acta 14(4-5): 274-292; Discussion: 293-300

Neuweiler, M. 1960: The treatment of open fractures. Vierteljahrsschrift für Schweizerische Sanitatsoffiziere. Journal Trimestriel des Officiers Suisses du Service de Sante. Rivista Trimestrale Degli Ufficiali Sanitari Svizzeri 37: 131-139

Mason, M.L. 1948: The treatment of open wounds of the hand. Minnesota Medicine 31(11): 1185; Passim

Mason, M.L. 1948: The treatment of open wounds of the hand. Surgical Clinics of North America 28(1): 4-26

Tuttle, W.M.; Langston, H.T.; Crowley, R.T. 1947: The treatment of organizing hemothorax by pulmonary decortication. Journal of Thoracic Surgery 16(2): 117-126; Discussion: 146-153

Buchan, J.F. 1958: The treatment of osteoarthritis. Practitioner 181(1081): 29-34

Fletcher, E. 1951: The treatment of osteoarthritis. Practitioner 166(994): 406-409

Hindenach, J.C.R. 1949: The treatment of osteoarthritis. Medical Press 221(26): 619-623

Kellgren, J.H. 1963: The treatment of osteoarthrosis. Reports on Rheumatic Diseases 15: 1-2

Melick, R.A. 1986: The treatment of osteoporosis. Medical Journal of Australia 144(12): 645-647

Wheatley, D. 1952: The treatment of otitis media. Medicine Illustrated 6(9): 443-447

Majoros, A.; Romics, M.ós.; Ali, A.; Hamvas, A.; Molnár, P.ét.J.óz.; Keszthelyi, A.; Nyirády, P.ét. 2021: The treatment of overactive bladder syndrome with onabotulinumtoxinA therapy. Orvosi Hetilap 162(36): 1459-1465

Pittinger, T.P.; Curran, D.; Hermans, M.H. 2020: The treatment of paediatric burns with concentrated surfactant gel technology: a case series. Journal of Wound Care 29(Suppl 6): S12-S17

Berk, J.E. 1953: The treatment of pancreatitis. Pennsylvania Medical Journal 56(4): 265-269

Thebaud, J. 1946: The treatment of paradentosis and its trends. Journal of the Canadian Dental Association 12: 39

Thebaud, J. 1946: The treatment of paradentosis and its various trends. Journal of the Canadian Dental Association 12: 149 Passim

Thebaud, J. 1946: The treatment of paradentosis and its various trends. Journal of the Canadian Dental Association 12: 251

Hardy, A.G. 1965: The treatment of paraplegia due to fracture-dislocations of the dorso-lumbar spine. Paraplegia 3(2): 112-123

Garaventa, A. 1948: The treatment of parapneumothoracic empyema with endopleuric penicillin. Archivio "e. Maragliano" di Patologia e Clinica 3(4): 1063-1070

Magee, K.R. 1958: The treatment of parkinsonism. Gp 18(4): 138-147

Gavey, C.J. 1947: The treatment of paroxysmal tachycardia. Practitioner 158(948): 512-514

van den Broek, T.A.A.; Brakenhoff, J.; de Widt-Levert, L.M. 2005: The treatment of patients with gastric carcinoma based on the results of Dutch studies. Nederlands Tijdschrift Voor Geneeskunde 149(15): 842; Author Reply 842-3

Ivashkin, V.T.; Kalinin, A.V. 1991: The treatment of peptic ulcer. Voenno-Meditsinskii Zhurnal 5: 38-42

Zeligman, V.S.; Shmakov, V.N.; Radugina, G.S.; Chernykh, S.N.; Zazimko, A.S. 1989: The treatment of peptic ulcer. Vrachebnoe Delo 4: 7-10

Barbezat, G.O. 1982: The treatment of peptic ulcer. New Zealand Medical Journal 95(720): 813-814

Fletcher, A.G. 1952: The treatment of peptic ulcer. Journal of the Christian Medical Association of India 27(4): 183-193

Melville, R.P. 1953: The treatment of peptic ulcer. Medical Journal of Australia 1(18): 644-645

Aaron, A.H. 1954: The treatment of peptic ulcer. New York State Journal of Medicine 54(3): 352-355

Patterson, M. 1955: The treatment of peptic ulcer. Mcgill Medical Journal 24(1): 12-18

Glenn, F.; Forkner, C.; Moore, S.W.; Almy, T.P. 1950: The treatment of peptic ulcer. Rhode Island Medical Journal 33(4): 179-185

Horsley, G.W. 1948: The treatment of peptic ulcer. Virginia Medical Monthly 75(6): 281-287

Chamberlain, D. 1948: The treatment of peptic ulcer. Medical World 69(2): 40-42

Gordon, A.H. 1948: The treatment of peptic ulcer. Canadian Medical Association Journal 58(1): 38-42

Beattie, A.D. 1948: The treatment of peptic ulcer by vagotomy. Annals of the Royal College of Surgeons of England 2(5): 248-260

Ellis, H. 2021: The treatment of peptic ulceration. Journal of Perioperative Practice 31(10): 399-400

Powell, R.N.; Alexander, A.G. 1965: The treatment of periodontal disease. British Dental Journal 119(9): 377-379

Powell, R.N.; Alexander, A.G. 1965: The treatment of periodontal disease. British Dental Journal 119(11): 474-476 Contd

Powell, R.N.; Alexander, A.G. 1965: The treatment of periodontal disease. British Dental Journal 119(12): 522

Powell, R.N.; Alexander, A.G. 1966: The treatment of periodontal disease. British Dental Journal 120(3): 111-113 Contd

Powell, R.N.; Alexander, A.G. 1966: The treatment of periodontal disease. British Dental Journal 120(4): 161-163 Contd

Powell, R.N.; Alexander, A.G. 1966: The treatment of periodontal disease. British Dental Journal 120(6): 251

Immertreu, W. 1966: The treatment of periodontal diseases. Zahnarztliche Praxis 17(3): 25-29

Judmaier, F. 1949: The treatment of peripheral circulatory disorders with Special regard to the old Frostbite. Wiener Klinische Wochenschrift 61(6): 85-90

Fleming, J. 1948: The treatment of pernicious anaemia. Modern Treatment Yearbook 1: 80-90

Eisenberg, S.E. 1951: The treatment of pernicious anemia. Connecticut State Medical Journal 15(1): 46-47

Kloek, J.; Ledeboer, B.C. 1948: The treatment of petit Epilepsy with Tridione (Absentol, Petidion) and with Ketogenic Diet. Nederlands Tijdschrift Voor Geneeskunde 92(7): 485-494

Lefrou, G. 1948: The treatment of phageic tropical ulcers based on pH. Revue Coloniale de Medecine and Chirurgie 20(160): 218-220

Lenshoek, C.H. 1948: The treatment of phantom pains. Nederlands Tijdschrift Voor Geneeskunde 92(46): 3800-3802

Wilson, H. 1948: The treatment of phlebothrombosis and thrombophlebitis. Journal of the Tennessee State Medical Association. Tennessee State Medical Association 41(2): 39-42

Jeanneret, H.; Pfister, C. 1945: The treatment of pleuro-pulmonary suppurations with penicillin. Revue Medicale de la Suisse Romande 65(11): 738-757

Robbie, G.A. 1949: The treatment of pneumococcal meningitis. Medical Journal of Australia 2(19): 676

Kershman, J.; Peterson, E. 1948: The treatment of pneumococcal meningitis. Canadian Medical Association Journal 59(6): 527-531

Detweiler, H.K. 1947: The treatment of pneumonia. Bulletin of the Academy of Medicine Toronto 20(5): 105-110

Arena, J.M. 1966: The treatment of poisoning. Clinical Symposia 18(1): 3-31

Hurwitz, A.; Klaassen, C. 1980: The treatment of poisoning. Rational Drug Therapy 14(3): 1-5

Binet, L.; Bochet, M.; Bour, H. 1948: The treatment of polio respiratory accidents; contribution to the study of steel lungs. Biologie Medicale 37(1-2): 1-38

Zischinsky, H. 1948: The treatment of polio with high doses of pyramid. Wiener Klinische Wochenschrift 60(3): 52

Perazzo, D.L.; Carnevali, N.S. 1960: The treatment of polycythemia vera. El Dia Medico 32: 182

Altemeier, W.A.; Hoxworth, P.I.; McELHINNEY, W.T.; Giuseffi, J.; Macmillan, B.; Todd, G. 1954: The treatment of portal hypertension. American Surgeon 20(12): 1235-1245

Storer, J. 1957: The treatment of portal hypertension. Ohio State Medical Journal 53(4): 416-418

Boĭko, V.V.; Krivoruchko, I.A.; Dotsenko, G.D.; Dotsenko, D.G.; Groma, V.G. 2000: The treatment of postoperative abdominal hernia. Klinichna Khirurhiia 10: 42-44

Gaehtgens, G. 1953: The treatment of pregnancy toxemias. Therapie der Gegenwart 92(1): 22-25

Hillebrand, H. 1964: The treatment of premenstrual aphthous ulcerative stomatitis with Agnolyt. Zeitschrift für Allgemeinmedizin 40(36): 1577

Bochinski, D.J.; Deng, D.Y.; Lue, T.F. 2003: The treatment of priapism--when and how?. International Journal of Impotence Research 15 Suppl. 5: S86-S90

Lendorf, A. 1948: The treatment of prostate hypertrophy and prostate cancer. Nordisk Medicin 39(30): 1441

Sarff, O.E. 1946: The treatment of prostatism. Journal-Lancet 66: 215-217

Wilson, C.C. 1947: The treatment of pruritus ani. JOURNAL. Kansas City Southwest Clinical Society 23(6): 15

Govaerts, J.P. 1963: The treatment of pseudocysts of the pancreas. Acta Gastro-Enterologica Belgica 26: 223-235

Laugier, P. 1976: The treatment of psoriasis. Annales de Dermatologie et de Syphiligraphie 103(5-6): 547-566

Mali, J.W.; Kuiper, J.P.; van de Staak, W.J.; Groels, A.P. 1975: The treatment of psoriasis. Nederlands Tijdschrift Voor Geneeskunde 119(3): 89-92

Rufli, T. 1975: The treatment of psoriasis. Schweizerische Rundschau für Medizin Praxis 64(28): 883-886

Rotstein, H.; Baker, C. 1990: The treatment of psoriasis. Medical Journal of Australia 152(3): 153-164

Doherty, V. 1988: The treatment of psoriasis. Practitioner 232(1454): 1007-1008; 1011-1012

Going, S. 1988: The treatment of psoriasis. Practitioner 232(1452): 824-827

Watson, A. 1985: The treatment of psoriasis. Australian Family Physician 14(10): 1082-1083

Lauharanta, J. 1993: The treatment of psoriasis. Duodecim; Laaketieteellinen Aikakauskirja 109(5): 441-447

Welsh, A.L. 1961: The treatment of psoriasis. Gp 24: 89-95

Haberfellner, H.; Rossiwall, B. 1976: The treatment of ptyalism in children with cerebral lesions. Münchener Medizinische Wochenschrift 118(27): 879-882

Hackney, R.L. 1971: The treatment of pulmonary embolism. Journal of the National Medical Association 63(5): 338-345

Efira, A. 1983: The treatment of pulmonary embolism. Revue Medicale de Bruxelles 4(5): 361-366

Von DE MERWE, C.F. 1946: The treatment of pulmonary embolism with intravenous physiological saline solution. South African Medical Journal 20: 166-169

Peckenschneider, L.E. 1955: The treatment of pulmonary emphysema. Journal of the Kansas Medical Society 56(9): 486-490

Castaing, R. 1949: The treatment of pulmonary suppurations with endobronchial penicillin. Journal de Medecine de Bordeaux et du Sud-Ouest 126(6): 257-265

Porteous, J.B. 1959: The treatment of pulmonary tuberculosis. South African Medical Journal 33(13): 265-267

Brod, J.J. 1951: The treatment of pulmonary tuberculosis. Mcgill Medical Journal 20(2): 83-90

Muschenheim, C. 1949: The treatment of pulmonary tuberculosis. Medical Bulletin 9(2): 56-63

Cole, F.H. 1948: The treatment of pulmonary tuberculosis. Memphis Medical Journal 23(1): 5-8

Salkin, D. 1947: The treatment of pulmonary tuberculosis. West Virginia Medical Journal 43(1): 16

White, B. 1946: The treatment of pulmonary tuberculosis. Bulletin of the Post-Graduate Committee in Medicine University of Sydney 2(7): 195-200

Robinson, E. 1962: The treatment of pulmonary tuberculosis amongst Africans in Bulawayo. Central African Journal of Medicine 8: 466-470

Boulin, R.; Bour, H. 1949: The treatment of pulmonary tuberculosis in diabetics with streptomycin. Les Entretiens de Bichat. Medecine. Entretiens de Bichat 30(3): 8-10

Newns, G.H. 1947: The treatment of pyelitis in children. Medical Press 217(23): 483-485

Wrong, N.M.; Smith, R.C.; Hudson, A.L.; Hair, H.C. 1951: The treatment of pyogenic skin infections with bacitracin ointment. Treatment Services Bulletin. Canada. DePartment of Veterans' Affairs 6(6): 257-261

Brown, O.F. 1946: The treatment of pyorrhoea. Mouth Mirror 21: 241-244

Hutchison, I.; Nocton, S.M. 1990: The treatment of ranula and salivary gland neoplasms. British Dental Journal 168(8): 318-319

Abaza, A. 1949: The treatment of rathrosis by intra-articular acid injections. Rhumatologie 5: 229-235

Ulrich, P. 1949: The treatment of rebellious pain of metastatic uterine cancer by radicotomy. Comptes Rendus de la Societe Francaise de Gynecologie 19(6): 154-156

Ramioul, H.; Crismer, R. 1949: The treatment of recto-sigmoid villous tumors by contact roentgentherapy. JournaldeRadiologied'ElectrologieandArchivesd'ElectriciteMedicale 30(5-6): 321

Sharif, K.W.; Arafat, A.F.; Wykes, W.C. 1991: The treatment of recurrent trichiasis with argon laser photocoagulation. Eye 5: 591-595

Otsubo, S.; Akiba, T. 2005: The treatment of refractory edema. Nihon Rinsho. Japanese Journal of Clinical Medicine 63(1): 140-143

Pfister, M. 1947: The treatment of refugees considered as a problem of mass psychology. Medecine et Hygiene 5(90): 10

Gryn, J.; Johnson, E.; Goldman, N.; Devereux, L.; Grana, G.; Hageboutros, A.; Fernandez, E.; Constantinou, C.; Harrer, W.; Viner, E.; Goldberg, J. 1997: The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon. Bone Marrow Transplantation 19(3): 221-226

Stalnaker, P.R. 1947: The treatment of renal colic with special emphasis on crystalluria. United States Naval Medical Bulletin 47(2): 297-301

Coller, F.A.; Campbell, K.N.; Iob, V. 1949: The treatment of renal insufficiency in the surgical patient. Alexander Blain Hospital Bulletin 8(1): 22-33

Coller, F.A.; Campbell, K.N.; Iob, V. 1948: The treatment of renal insufficiency in the surgical patient. Annals of Surgery 128(3): 379-390

Cibert, J.; Cavailher, H. 1947: The treatment of renal staphylococcal disease with penicillin. Journal d'Urologie Medicale et Chirurgicale 53(7): 228-233

Kraan, J.K. 1959: The treatment of renal tuberculosis. Nederlands Tijdschrift Voor Geneeskunde 103: 1937-1942

Robert, J.P. 1949: The treatment of renal tuberculosis. Concours Medical 71(40): 2235-2239

Höpping, W.; Renelt, P. 1974: The treatment of retinoblastoma. Modern Problems in Ophthalmology 12: 580-587

Ellsworth, R. 1971: The treatment of retinoblastoma. Transactions of the Australian College of Ophthalmologists 3: 100-110

Ellsworth, R.M. 1968: The treatment of retinoblastoma. Bibliotheca Ophthalmologica: Supplementa Ad Ophthalmologica 75: 142-148

Stallard, H.B. 1968: The treatment of retinoblastoma. Bibliotheca Ophthalmologica: Supplementa Ad Ophthalmologica 75: 149-173

Epstein, F.H. 1954: The treatment of reversible uremia. Yale Journal of Biology and Medicine 27(1): 53-69

Bolland 1947: The treatment of rheumatic affections in hot waters. Bulletin de la Societe Medicale de Pau 47(3): 2674-2689

Wasson, V.P. 1947: The treatment of rheumatic fever. Journal of the American Medical Women's Association 2(3): 115

Shapiro, M.J. 1945: The treatment of rheumatic fever. Journal-Lancet 65: 400

Bronzov, I.A. 1969: The treatment of rheumatism. Meditsinskaia Sestra 28(3): 18-22

Nuki, G.; Kempsill, C.D. 1968: The treatment of rheumatoid arthritis. Nursing Times 64(42): 1411-1412

Zhang, N.Z. 1993: The treatment of rheumatoid arthritis. Zhonghua Nei Ke Za Zhi 32(8): 508-510

Trommer, P.R.; Gellman, M.B.; Smith, R.T.; Hollander, J.L.; Maguire, E.F. 1954: The treatment of rheumatoid arthritis. Journal of the American Medical Women's Association 9(7): 205-215

Delicati, L. 1950: The treatment of rheumatoid arthritis. Medical Press 224(7): 165-169

Davison, R. 1946: The treatment of rheumatoid arthritis. Stanford Medical Bulletin 4: 15-20

Babić-Naglić, D. 2014: The treatment of rheumatoid arthritis. Reumatizam 61(2): 55-59

Strauss, E.B. 1949: The treatment of schizophrenia. Medical Press 221(19): 454-457

Strauss, E.B. 1949: The treatment of schizophrenia. ST. Bartholomew's Hospital Journal 53(7): 134-137

Beerman, H.; Stokes, J.H. 1949: The treatment of scleroderma. American Journal of the Medical Sciences 217(4): 453-461

Wilson, F.C. 1967: The treatment of scoliosis. North Carolina Medical Journal 28(4): 139-143

Roaf, R. 1967: The treatment of scoliosis. International Surgery 47(3): 226-235

Lance, P. 1953: The treatment of scoliosis. Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur 39(5-6): 613-614

Kelley, J.H.; Gibson, D.N. 1961: The treatment of scoliosis. JOURNAL. Iowa State Medical Society 51: 412-415

Danna, J.A. 1946: The treatment of sebaceous cyst by electrosurgical marsupialization. Annals of Surgery 123: 952-956

Juster, E. 1945: The treatment of seborrheic and pityriastic alopecia with cadic solutions. Annales de Dermatologie et de Syphiligraphie 5: 223

Behrendt, H. 1948: The treatment of seriously ill pulmonary tuberculosis. Medizinische Monatsschrift 2(8): 287-290

Quesada, R. 2021: The Treatment of Severe Aortic Stenosis in the Presence of Mitral Regurgitation: there Is Much to be Learned. Cardiovascular Revascularization Medicine: Including Molecular Interventions 32: 41-42

Page, I.; Taylor, R.D.; Corcoran, A.C. 1952: The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine. Die Medizinische 20(48): 1516-1518

Steppert, A. 1955: The treatment of severe burns. Wiener Medizinische Wochenschrift 105(23): 465-467

Li, X.; Xing, Y-Fang.; Lin, Q.; Dong, M.; Wan, X-Bo.; Wu, X-Yuan. 2012: The treatment of severe hepatitis B virus reactivation after chemotherapy. Nature Reviews. Clinical Oncology 9(6): 350; Author Reply 350

Dwyer, B.; Lazarus, L. 1957: The treatment of severe tetanus. Medical Journal of Australia 44(7): 249-250

Guzey, M.; Ozardali, I.; Kilic, A.; Basar, E.; Dogan, Z.; Satici, A.; Karadede, S. 2001: The treatment of severe trachomatous dry eye with canalicular silicone plugs. Eye 15(Pt 3): 297-303

Walt, A.J.; Wilson, R.F. 1975: The treatment of shock. Advances in Surgery 9: 1-39

Schöber, J.G. 1985: The treatment of shock. Monatsschrift Kinderheilkunde: Organ der Deutschen Gesellschaft für Kinderheilkunde 133(6): 399-403

Laroche, G.; Laroche, C. 1961: The treatment of simple goiters. Semaine Medicale Professionelle et Medico-Sociale 37: 1685-1691

Simonton, K.M. 1949: The treatment of sinusitis. Arizona Medicine 6(8): 15-18

Stein, J.J. 1959: The treatment of skin cancer. Mississippi Valley Medical Journal 81: 267-270

Traenkle, H.L. 1955: The treatment of skin cancer. New York State Journal of Medicine 55(14): 2060-2063

Sawyer, K.C. 1952: The treatment of skin cancer. Arizona Medicine 9(1): 26-27

Degos, R. 1948: The treatment of skin cancer. Paris Medical 38(4): 55-60

Baillet, P. 1949: The treatment of skin conditions with mineral waters. Archives Hospitalieres 21(6): 187-195

Baillet, P. 1949: The treatment of skin conditions with mineral waters. La Presse Thermale et Climatique 86(3-4): 89-93 Disc. 95

Halstead, E.; Sullivan, E.; Zambelli, Z.; Ellis, J.G.; Dimitriou, D. 2021: The treatment of sleep problems in autistic adults in the United Kingdom. Autism: the International Journal of Research and Practice 25(8): 2412-2417

Teodori, U. 1945: The treatment of slow endocarditis with penicillin. Rivista Critica di Clinica Medica 45(3-5): 342-349

Lichtwitz, A.; Bernal, P. 1946: The treatment of slow malignant endocarditis with penicillin. Therapeutische Umschau und Medizinische Bibliographie. Revue Therapeutique et Bibliographie Medicale 3(7): 164; Passim

De Gennes, L.; Cournot, L. 1945: The treatment of slow malignant endocarditis with penicillin. La Presse Medicale 53: 492

Wirz, P. 1948: The treatment of snake bites and insect bites in the Sinhalese. Schweizerische Drogisten Zeitung 48(29): 509-513

Brossy, J. 1977: The treatment of snakebite. South African Medical Journal 51(12): 390-391

Christensen, P.A. 1969: The treatment of snakebite. South African Medical Journal 43(41): 1253-1258

Stimson, A.C.; Engelhardt, H.T. 1960: The treatment of snakebite. Journal of Occupational Medicine.: Official Publication of the Industrial Medical Association 2: 163-168

Trinca, G.F. 1963: The treatment of snakebite. Medical Journal of Australia 50(1): 275-280

Hu, W. 2020: The treatment of soft tissue defects of the lower and upper limb. Annales de Chirurgie Plastique et Esthetique 65(5-6): 343-344

Kratzer, L.; Heinz, P.; Schennach, R.; Schröder, J. 2021: The treatment of somatic symptoms in childhood abuse-related PTSD: do we need a modular approach?. Journal of Psychiatric Research 141: 223-225

Tronconi, V. 1948: The treatment of some extra-pyramidal syndromes with preparations of the aminoaromatic series. Minerva Medica 39(22): 551

Cavadi, A. 1948: The treatment of spastic paralysis. Sicilia Medica 5(5-6): 110-120

Hagenbach, U.; Luz, S.; Ghafoor, N.; Berger, J.M.; Grotenhermen, F.; Brenneisen, R.; Mäder, M. 2007: The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury. Spinal Cord 45(8): 551-562

Bocage, A.; Mercier, P.; Pillet, J. 1947: The treatment of staphylococcal infections by specific toxoid: results, details. Revue du Corps de Sante Militaire 3(2): 123-136

Van Huffelen, A.C. 1983: The treatment of status epilepticus. Nederlands Tijdschrift Voor Geneeskunde 127(44): 2003-2009

Jacoby, N.M. 1957: The treatment of status epilepticus in children. Practitioner 178(1065): 373-376

Bellini, E. 1949: The treatment of stenocardias; the compounds of the diethylamine series. Gazzetta Sanitaria 20(3): 116-121

Neuschuller, I. 1947: The treatment of strabismus in early childhood. Il Policlinico. Sezione Pratica 54(32): 896

Norton, L.; Myers, A. 2021: The treatment of streptococcal tonsillitis/pharyngitis in young children. World Journal of Otorhinolaryngology - Head and Neck Surgery 7(3): 161-165

Boand, A.V.; Herrold, R.D.; Kamp, M. 1955: The treatment of stubborn urinary infections with a new antibiotic: cycloserine. Antibiotics Annual 3: 165-168

January, L.E.; Theilen, E.O. 1952: The treatment of subacute bacterial endocarditis. JOURNAL. Iowa State Medical Society 42(4): 167-171

Cookson, H. 1949: The treatment of subacute bacterial endocarditis. Medical Press 222(24): 560-563

Glaser, R.J. 1948: The treatment of subacute bacterial endocarditis. American Practitioner and Digest of Treatment 2(7): 436-442

Gefter, W.I.; Maher, I.E.; Dworin, M. 1946: The treatment of subacute bacterial endocarditis. Clinics 5(1): 58-81

Waring, J.J. 1946: The treatment of subacute bacterial endocarditis. Clinical Medicine 53: 260

Moffitt, H.; Kerr, W. 1945: The treatment of subacute bacterial endocarditis. California Medicine 65(4): 189-191

Fisher, V.R. 1946: The treatment of subacute bacterial endocarditis. Journal of the American Osteopathic Association 46(3): 167-170

Perry, C.B. 1947: The treatment of subacute bacterial endocarditis with penicillin. BristolMedico-ChirurgicalJournal 64(229): 6

Meals, W.G. 1950: The treatment of surgical shock. Transactions of the American Laryngological Rhinological and Otological Society Inc 54th Meeting: 324-336

Salamon, P.B. 1999: The treatment of symptomatic os acromiale. Journal of Bone and Joint Surgery. American Volume 81(8): 1198

Rasmussen, D.H. 1969: The treatment of syphilis. Survey of Ophthalmology 14(3): 184-197

King, A.J. 1965: The treatment of syphilis. Practitioner 195(169): 589-595

Fiumara, N.J. 1960: The treatment of syphilis. Connecticut Medicine 24: 78-81

Fiumara, N.J. 1961: The treatment of syphilis. Tufts Folia Medica 7: 89-94

Epstein, N. 1951: The treatment of syphilis. American Practitioner and Digest of Treatment 2(4): 317-319

Kanee, B. 1950: The treatment of syphilis. Canadian Medical Association Journal 63(3): 269-272

Lloyd, V.E. 1949: The treatment of syphilis. Practitioner 162(971): 349-357

Mashkilleison, L.H. 1948: The treatment of syphilis. Sovetskaia Meditsina 12(1): 32-34

Brockman, G. 1948: The treatment of syphilis. Kentucky Medical Journal 46(7): 263-269

Kimbrough, R. 1947: The treatment of syphilis. Virginia Medical Monthly 74(7): 321

Webster, B.; McDERMOTT, W. 1946: The treatment of syphilis. New York State Journal of Medicine 46(23): 2651; 2760

Neave, H.J. 1947: The treatment of syphilis. Journal of the American Medical Women's Association 2(3): 114

Hall, V.A. 1947: The treatment of syphilis. Memphis Medical Journal 22(4): 56-59

Heller, J.R. 1948: The treatment of syphilis with penicillin. ABSTRACTS. International Congress on Tropical Medicine and Malaria 56(4th Congr): 11

Heyman, A. 1946: The treatment of syphilis with penicillin. Journal of the Medical Association of Georgia 35: 206-208

Kjellberg, G. 1947: The treatment of syphilis with penicillin and arsenicals in different countries. La Prophylaxie Antivenerienne 19(12): 799-803

Degos, R. 1946: The treatment of syphilitic aorto-myocarditis with cures of 200 successive injections of mercury cyanide. Annales de Dermatologie et de Syphiligraphie 6(9): 468

Bellini, E. 1948: The treatment of tachycardias with acetylcholine. Gazzetta Sanitaria 19(4-5): 98-101

Raja, M. 1996: The treatment of tardive dyskinesia. Schweizer Archiv für Neurologie und Psychiatrie 147(1): 13-18

Seward, M.H. 1972: The treatment of teething in infants. A review. British Dental Journal 132(1): 33-36

Grosbuis, S.; Goulon, M. 1998: The treatment of tetanus. La Revue du Praticien 48(5): 478-481

Labadie, P. 1952: The treatment of tetanus. Journal de Medecine de Bordeaux et du Sud-Ouest 129(12): 1169-1171

Saint, E.G.; Joske, R.A.; Stubbe, J.L. 1953: The treatment of tetanus. Medical Journal of Australia 1(11): 361-364

Hills, W.J.; Sykes, E.M. 1959: The treatment of tetanus. American Surgeon 25(1): 35-37

Girard 1945: The treatment of tetanus. Journal de Medecine de Lyon 26: 785-787

Tucker, J.S.; Lasater, G.M. 1949: The treatment of tetanus. Bulletin of the University of Minnesota Hospitals and Minnesota Medical Foundation. University of Minnesota. Hospitals 21(9): 118-127

Zhang, J.; Yin, P.; Han, B.; Zhao, J.; Yin, B. 2021: The treatment of the atrophic clavicular nonunion by double-plate fixation with autogenous cancellous bone graft: a prospective study. Journal of Orthopaedic Surgery and Research 16(1): 22

Birch, E.M. 1953: The treatment of the cerebral palsy child in a general hospital. PhysioTherapy 39(3): 52-54

Hansen, J.D. 1970: The treatment of the dehydrated Bantu child. South African Medical Journal 44(48): 1395-1396

Vanderzijpen 1948: The treatment of the fibromyoma. Belgisch Tijdschrift Voor Geneeskunde 4(19): 898-907

Slingenberg, J.H. 1948: The treatment of the fractures of the long leg bones with the marrow pen according to Küntscher. Nederlands Tijdschrift Voor Geneeskunde 92(46): 3795-3800

Grosfeld, J.C.M.; Van Der Lugt, L. 1948: The treatment of the luetic gravida. Nederlands Tijdschrift Voor Geneeskunde 92(30): 2237-2241

Dollfus, P.; Molé, L. 1969: The treatment of the paralysed bladder after spinal injury in the accident unit of Colmar. Paraplegia 7(3): 204-205

Tolstoi, E. 1959: The treatment of the pregnant diabetic. Harofe Haivri. Hebrew Medical Journal 1: 219-226

Mertens, E. 1947: The treatment of the typical spoke fracture based on modern knowledge. Das Deutsche Gesundheitswesen 2(21): 671

Mays, J.L. 1947: The treatment of thermal burns. Journal of the Medical Association of Georgia 36(7): 263-268

Hirshfeld, J.W. 1946: The treatment of thermal burns. American Journal of Nursing 46: 158-162

Iarussi, T.; Cipollone, G.; Quitadamo, S.; Altobelli, S.; Sacco, R. 2003: The treatment of thoracic empyema by video-assisted thoracic surgery (VATS). Annali Italiani di Chirurgia 74(1): 9-12

Paddock, R. 1955: The treatment of threatened abortion. Illinois Medical Journal 108(3): 167-170

Murphy, H.S. 1961: The treatment of threatened abortion. Journal of the Medical Society of New Jersey 58: 60-64

Clayton, S.G. 1949: The treatment of threatened abortion. Practitioner 163(978): 557-559

Plooij, M. 1948: The treatment of thrombosis with anticoagulants. Nederlands Tijdschrift Voor Geneeskunde 92(3): 190-202

Plooij, M. 1948: The treatment of thrombosis with dicumarol. Nederlands Tijdschrift Voor Geneeskunde 92(13): 908-911

Newton, A.; Maxwell, I. 1947: The treatment of thyreotoxicosis by concurrent administration of thiouracil and iodine. Medical Journal of Australia 1(2): 61

Poate, H.R.G. 1947: The treatment of thyreotoxicosis by concurrent administration of thiouracil and iodine. Medical Journal of Australia 1(5): 159

Poate, H.R.G. 1947: The treatment of thyreotoxicosis by concurrent administration of thiouracil and iodine. Medical Journal of Australia 1(8): 254

Voronetskiĭ, I.B. 1990: The treatment of thyroid cancer. Meditsinskaia Radiologiia 35(1): 53-57

Leeper, R.D. 1983: The treatment of thyroid cancer. Progress in Clinical and Biological Research 116: 139-153

McCLINTOCK, J.C. 1955: The treatment of thyroid cancer. New York State Journal of Medicine 55(16): 2376-2378

Fitzgibbons, S.C.; Brams, D.M.; Wei, J.P. 2008: The treatment of thyroid cancer. American Surgeon 74(5): 389-399

Bigelow, R.R. 1959: The treatment of thyroid carcinoma. Journal of the Tennessee State Medical Association. Tennessee State Medical Association 52(3): 78-79

Schlicke, C.P. 1965: The treatment of thyroid disease. Surgery Gynecology and Obstetrics 121(5): 1092-1094

Mason, A.S. 1969: The treatment of thyrotoxicosis. Nursing Times 65(7): 202-203

Du, R.Y.; Mao, T.S.; Huang, C.T.; Yang, Z.Y.; Huo, B.Z.; Zhang, X.J. 1984: The treatment of thyrotoxicosis. Chinese Medical Journal 97(9): 684-688

Greene, R. 1952: The treatment of thyrotoxicosis. Practitioner 169(1011): 237-242

Martin, L. 1956: The treatment of thyrotoxicosis. Practitioner 176(1056): 592-599

Duvoir, M.; Derobert, L.; Gaultier, M. 1949: The treatment of toxic agranulocytoses in particular benzolic; Clinical and experimental study. Archives des Maladies Professionnelles de Medecine du Travail et de Securite Sociale 10(1): 5-25

Marks, E.O. 1946: The treatment of trachoma. British Journal of Ophthalmology 30: 213-215

Rouveix, J.; Pellet, C.; Du Lac, G. 1949: The treatment of trauma and their aftermath in mineral waters. La Presse Thermale et Climatique 86(3-4): 83-86

Rouveix, J. 1949: The treatment of trauma and their aftermath in mineral waters. Archives Hospitalieres 21(5): 150; Passim

Pennypacker, J.B. 1953: The treatment of traumatic paraplegia. Journal of Bone and Joint Surgery. British Volume 35-B(4): 517-518

Varangot, J.; Zaidman, H. 1948: The treatment of trichomonas vaginitis with furalone. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 24(55): 1805

Smyth, E.A. 1946: The treatment of tropical ulcer. Journal of the Royal Army Medical Corps 87(3): 141

Brewin, A. 1976: The treatment of tuberculosis. Rational Drug Therapy 10(10): 1-5

Collins, T.F. 1981: The treatment of tuberculosis. South African Medical Journal 60(20): 767

Donald, P.R. 2007: The treatment of tuberculosis in childhood. South African Medical Journal 97(10 Part 2): 992-994

Figi, F.A.; Hinshaw, H.C. 1946: The treatment of tuberculosis of the larynx with streptomycin. Transactions - American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology 51: 93-100

Sinitsyn, M.V.; Kalinina, M.V.; Belilovskiy, E.M.; Galstyan, A.S.; Reshetnikov, M.N.; Plotkin, D.V. 2020: The treatment of tuberculosis under current conditions. Terapevticheskii Arkhiv 92(8): 86-94

Ruiter, D. 1955: The treatment of tuberculous empyema. Archivum Chirurgicum Neerlandicum 7(2): 89-104

Rochemaure, J. 1961: The treatment of tuberculous meningitis. Le Progres Medical 89: 346-350

MacLEAN, K.S. 1951: The treatment of tuberculous meningitis. Guy's Hospital Gazette 65(1640): 199-203

Radulescu, A.; Priboianu, M.; Ionescu, M.; Meghea, G. 1959: The treatment of tuberculous spondylitis. Rumanian Medical Review 3(1): 55-59

Girard 1946: The treatment of typhoid fever. Journal de Medecine de Lyon 27(636): 517-521

Truelove, S.C. 1981: The treatment of ulcerative colitis. Schweizerische Medizinische Wochenschrift 111(37): 1342-1346

Turunen, U.; Järvinen, H.J. 1993: The treatment of ulcerative colitis. Duodecim; Laaketieteellinen Aikakauskirja 109(2): 145-151

Svartz, N. 1954: The treatment of ulcerative colitis. Gastroenterology 26(1): 26-28 Passim

Hughes, E.S. 1956: The treatment of ulcerative colitis. Medical Journal of Australia 43(4): 130-134

Cullinan, E.R.; Macdougall, I.P. 1957: The treatment of ulcerative colitis. Practitioner 179(1073): 549-560

Spencer, J.A.; Kirsner, J.B. 1962: The treatment of ulcerative colitis. American Journal of Gastroenterology 37: 17-23

Truelove, S.C. 1962: The treatment of ulcerative colitis. Practitioner 189: 269-281

Hughes, E.S. 1959: The treatment of ulcerative colitis. New Zealand Medical Journal 58: 287-291

Hardy, T.L. 1946: The treatment of ulcerative colitis. Medical Press 216(11): 183-186

Gounelle, H.; Marche, J. 1947: The treatment of undernourishment with soy flour. Helvetica Medica Acta 14(4-5): 602-605

Riddett, S.A. 1947: The treatment of unerupted molar teeth. Medical Press 218(11): 234-237

Fiori, L.; Serrao, A.; Ferretti, A.; Chistolini, A. 2021: The treatment of upper extremities deep vein thrombosis related to thoracic outlet syndrome with direct oral anticoagulants. Phlebology 36(4): 329-330

Harmankaya, C. 1984: The treatment of urethral strictures. Turkish Journal of Pediatrics 26(1-4): 169-173

Barton, W.L. 1952: The treatment of urinary bilharzia. East African Medical Journal 29(4): 144-147

Secretan, M. 1954: The treatment of urinary infections. Gazette Medicale de France 61(5): 331-339

Vernet, D. 1963: The treatment of urinary infections. Revue Medicale de la Suisse Romande 83: 238-241

Kimbrough, J.C. 1951: The treatment of urinary tract infection. United States Armed Forces Medical Journal 2(7): 1061-1066

Egger, K. 1955: The treatment of urinary tract infections. Praxis 44(5): 99-101

Burns, E.; Peiser, I. 1956: The treatment of urologic complications in gynecology. Journal of Urology 75(3): 438-442

Hatisuka, S. 1948: The treatment of urticaria. Fukuoka Igaku Zasshi 39(2): 73-82

Prado, C. 1946: The treatment of uterine cancer. Hospital 29: 633-637

Kimbrough, R.A. 1951: The treatment of uterine prolapse. Mississippi Doctor 28(12): 399-402

Kimbrough, R.A. 1947: The treatment of uterine prolapse. New Orleans Medical and Surgical Journal 100(1): 16-20

Salmond, M. 1946: The treatment of uterine prolapse. Medical Press 215: 388-391

Perkins, E.S. 1960: The treatment of uveitis. Transactions of the Pacific Coast Oto-Ophthalmological Society Annual Meeting 41: 274-281

Ramelet, A.A. 1989: The treatment of varicose ulcers. Therapeutische Umschau. Revue Therapeutique 46(2): 128-132

Simpson, W. 1960: The treatment of varicose ulcers. Practitioner 184: 371-372

Waibel, P. 1976: The treatment of varicose veins. Schweizerische Rundschau für Medizin Praxis 65(14): 393-394

Keeman, J.N. 1976: The treatment of varicose veins. Nederlands Tijdschrift Voor Geneeskunde 120(49): 2156-2166

Dick, E.T. 1966: The treatment of varicose veins. New Zealand Medical Journal 65(405): 310-313

Cotton, L.T. 1971: The treatment of varicose veins. Practitioner 206(233): 352-358

Hoffmann, G. 1953: The treatment of varicose veins. Zeitschrift für Arztliche Fortbildung 47(7): 240-241

Clark, J.H. 1953: The treatment of varicose veins. American Surgeon 19(8): 750-755

Popper, H.L. 1954: The treatment of varicose veins. American Practitioner and Digest of Treatment 5(3): 212-214

Fraser, I. 1955: The treatment of varicose veins. Practitioner 175(1047): 267-275

Macpherson, A.I. 1959: The treatment of varicose veins. Practitioner 183: 11-18

Handley, R.S. 1951: The treatment of varicose veins. Practitioner 166(993): 228-235

Fratkin, L.B.; Jackes, H.L. 1951: The treatment of varicose veins. Canadian Medical Association Journal 65(4): 367-372

Foote, H.R. 1947: The treatment of varicose veins. Pharmaceutical Journal 104(4353): 223

Mauer, R.T. 1945: The treatment of varicose veins. BULLETIN. Creighton University. School of Medicine 3: 47-49

Lyall, D. 1946: The treatment of varicose veins. Surgery Gynecology and Obstetrics 82: 332-341

Rob, C.G. 1947: The treatment of varicose veins of the legs. ST. Thomas's Hospital Gazette 45(3): 85-89

De Jong, R.N. 1959: The treatment of vascular headaches. Gp 19(4): 147-154

Sommelet, J. 1953: The treatment of vascular tumors of the brain. Revue Medicale de Nancy 78: 169-203; Contd

Comel, M. 1948: The treatment of venereal diseases with the dermatophilactic endermic method. Minerva Medica 39(43 Part 2): 429-431

Deschamps, P.N. 1948: The treatment of veno-capillary insufficiency of the lower limbs (cellulite-acrocyanosis-acroasphyxietrophedema) by subcutaneous injections of thermal gas from Royat. Gazette Medicale de France 55(10): 357

Aizawa, T. 1965: The treatment of vertigo. Jibi Inkoka Otolaryngology 37(7): 605-614

Mayoux, R. 1955: The treatment of vertigo. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 31(52-53): 2789-2791

Spellberg, M.A. 1969: The treatment of viral hepatitis. American Journal of Gastroenterology 51(1): 15-34

Savoye, M.B. 1968: The treatment of viral hepatitis. Journal de Medecine de Lyon 49(135): 133-135

Leaver, P.K. 1994: The treatment of vitreoretinal scar tissue. Eye 8: 210-216

Lorenz, O. 1947: The treatment of vocal cord paralysis, especially via an initial autoplastic bone implantation in the vocal cord after paralysis. Medizinische Monatsschrift 1(11): 496-499

Thorne, N. 1968: The treatment of warts. British Journal of Clinical Practice 22(7): 313-316

Hellier, F.F.; Roberts, S.O.; Whitefield, M. 1969: The treatment of warts. Practitioner 202(213): 67-68

Carney, R.G. 1957: The treatment of warts. American Practitioner and Digest of Treatment 8(10): 1553-1557

Ginsberg, J.E. 1957: The treatment of warts. Journal-Lancet 77(12): 462-464

Ginsberg, J.E. 1962: The treatment of warts. Chicago Medicine 64: 7

Bour, H.; Hebert-Jouas 1953: The treatment of whooping cough. Progressos da Medicina 81(5): 99-100

Zischinsky, H. 1959: The treatment of whooping cough. Neue Osterreichische Zeitschrift für Kinderheilkunde 4: 158-164

Pitt, C.K. 1946: The treatment of whooping cough. Journal of the Medical Association of the State of Alabama 16: 139-143

Bertrand, P.; Trillat, A. 1948: The treatment of, inequalities in length of the lower limbs during growth. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 24(88): 2868

Zheng, Y.; Ding, X.; Zou, D.; Zhang, F.; Qin, C.; Yang, H.; Mo, W.; Ding, Y.; Yu, Y. 2020: The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience. Cancer Biology and Therapy 21(8): 675-687

Von STOCKERT, F.G. 1947: The treatment problem in psychiatry. Deutsche Medizinische Wochenschrift 72(21-22): 276-279

Skotnicky, J. 1946: The treatment problem of acute bacterial infections. Wiener Medizinische Wochenschrift 96(14-15): 91-93

Zhang, Y.; Fu, Y. 2021: The treatment progress of obstructive sleep apnea in children. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 35(8): 756-760

Stedman, M.; Whyte, M.B.; Lunt, M.; Albanese, M.; Livingston, M.; Gadsby, R.; Hackett, G.; Anderson, S.G.; Heald, A.H. 2020: The treatment rate of erectile dysfunction (ED) in younger men with type 2 diabetes is up to four times higher than the equivalent non-diabetes population. International Journal of Clinical Practice 74(9): E13538

Denzler, B. 2021: The treatment terrifies me more than the diagnosis. Bmj 372: N543

Buoni, M. 1949: The treatment with metallic aluminum of the deeply bruised and widely lacerated lesions of the hand. Lo Sperimentale 99(9-10): 479-490

Rikkert, M.G.M.Olde. 2004: The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness. Nederlands Tijdschrift Voor Geneeskunde 148(48): 2416; Author Reply 2416-7

Geurts, A.C.H.; Lem, F.C. 2004: The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness. Nederlands Tijdschrift Voor Geneeskunde 148(48): 2417; Author Reply 2417

Lin, W.; Li, N.; Gu, T.; Tang, C.; Liu, G.; Du, B.; Wei, R. 2021: The treatment zone size and its decentration influence axial elongation in children with orthokeratology treatment. Bmc Ophthalmology 21(1): 362

Xu, Q.-L.; Li, H.; Zhu, Y.-J.; Xu, G. 2020: The treatments and postoperative complications of esophageal cancer: a review. Journal of Cardiothoracic Surgery 15(1): 163

Reznick, D. 2020: The tree and the table: Darwin, Mendeleev and the meaning of 'theory'. Philosophical Transactions. Series a Mathematical Physical and Engineering Sciences 378(2180): 20190309

Nasir, A.; Mughal, F.; Caetano-Anollés, G. 2021: The tree of life describes a tripartite cellular world. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 43(6): E2000343

Salvi, D.; Tavladoraki, P. 2020: The tree of life of polyamine oxidases. Scientific Reports 10(1): 17858

Sischo, D.R.; Hadfield, M.G. 2021: The tree snail on Rota Island, Northern Mariana Islands, long identified as Partula gibba (Partulidae), is a different species. Zookeys 1037: 105-118

Mignotte, A.; Garros, C.; Gardès, L.; Balenghien, T.; Duhayon, M.; Rakotoarivony, I.; Tabourin, L.; Poujol, L.éa.; Mathieu, B.; Ibañez-Justicia, A.; Deniz, A.; Cvetkovikj, A.; Purse, B.V.; Ramilo, D.W.; Stougiou, D.; Werner, D.; Pudar, D.; Petrić, D.ša.; Veronesi, E.; Jacobs, F.; Kampen, H.; Pereira da Fonseca, I.; Lucientes, J.; Navarro, J.; de la Puente, J.M.; Stefanovska, J.; Searle, K.R.; Khallaayoune, K.; Culverwell, C.L.; Larska, M.; Bourquia, M.; Goffredo, M.; Bisia, M.; England, M.; Robin, M.; Quaglia, M.; Miranda-Chueca, M.Án.; Bødker, R.é; Estrada-Peña, R.; Carpenter, S.; Tchakarova, S.; Boutsini, S.; Sviland, S.ål.; Schäfer, S.M.; Ozoliņa, Z.; Segliņa, Z.; Vatansever, Z.; Huber, K. 2020: The tree that hides the forest: cryptic diversity and phylogenetic relationships in the Palaearctic vector Obsoletus/Scoticus Complex (Diptera: Ceratopogonidae) at the European level. Parasites and Vectors 13(1): 265

Clackett, S.P.; Porter, T.J.; Lehnherr, I. 2021: The tree-ring mercury record of Klondike gold mining at Bear Creek, central Yukon. Environmental Pollution 268(Part B): 115777

Ponnu, J.; Schlereth, A.; Zacharaki, V.; Działo, M.A.; Abel, C.; Feil, R.; Schmid, M.; Wahl, V. 2020: The trehalose 6-phosphate pathway impacts vegetative phase change in Arabidopsis thaliana. Plant Journal: for Cell and Molecular Biology 104(3): 768-780

Takaya, Y.; Yasukawa, K.; Kawasaki, T.; Fujinaga, K.; Ohta, J.; Usui, Y.; Nakamura, K.; Kimura, J-Ichi.; Chang, Q.; Hamada, M.; Dodbiba, G.; Nozaki, T.; Iijima, K.; Morisawa, T.; Kuwahara, T.; Ishida, Y.; Ichimura, T.; Kitazume, M.; Fujita, T.; Kato, Y. 2018: The tremendous potential of deep-sea mud as a source of rare-earth elements. Scientific Reports 8(1): 5763

Groffik, D.; Frömel, K.; Vorlíček, M.; Polechoński, J. 2020: The trend and structure of adolescents' weekly step count in the context of the Polish school environment. Annals of Agricultural and Environmental Medicine: Aaem 27(3): 442-447

Lin, C-Han.; Shu, C-Chung.; Hsu, C-Lin.; Cheng, S-Lung.; Wang, J-Yuan.; Yu, C-Jen.; Lee, L-Na. 2016: The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease. Scientific Reports 6: 37266

Hosseinkhani, S.; Aazami, H.; Hashemi, E.; Dehghanbanadaki, H.; Adibi-Motlagh, B.; Razi, F. 2021: The trend in application of omics in type 2 diabetes researches; a bibliometric study. Diabetes and Metabolic Syndrome 15(5): 102250

Carvello, M.; Di Candido, F.; Greco, M.; Foppa, C.; Maroli, A.; Fiorino, G.; Cecconi, M.; Danese, S.; Spinelli, A. 2020: The trend of C-Reactive protein allows a safe early discharge after surgery for Crohn's disease. Updates in Surgery 72(4): 985-989

Hong, J. 2021: The trend of eye bacterial species distribution and drug resistance in China. Chinese Journal of Ophthalmology 57(10): 721-723

Lin, F-H.; Chu, N-F.; Hsieh, A-T. 2012: The trend of hypertension and its relationship to the weight status among Taiwanese young adolescents. Journal of Human Hypertension 26(1): 48-55

Li, W.; Wei, L.; Wang, B.; Gao, S.; Huang, T.; Li, Z.; Bhattarai, R.; Wang, H.; Guo, Y.; Chen, C. 2021: The trend of indirect anastomosis formation in a 2-vessel occlusion plus encephalo-myo-synangiosis rat model. Annals of Translational Medicine 9(1): 19

Cho, S.-H.; Kim, Y.-M.; Lee, J.-H.; Kim, H.-S.; Song, J.-S. 2020: The trend of prevalence of pain in Korea from 2005 to 2016. Korean Journal of Pain 33(4): 352-358

Mu, Y.; Wang, X.; Wang, Y.; Liu, Z.; Li, M.; Li, X.; Li, Q.; Zhu, J.; Liang, J.; Wang, H. 2021: The trends and associated adverse maternal and perinatal outcomes of labour neuraxial analgesia among vaginal deliveries in China between 2012 and 2019: a real-world observational evidence. Bmc Medicine 19(1): 74

Khoshhal, S.Q.; Albasri, A.M.; Morsy, M.M.F.; Alnajjar, A.A. 2020: The trends and patterns of congenital heart diseases at Madinah Cardiac Center, Madinah, Saudi Arabia. Saudi Medical Journal 41(9): 977-983

Zakharova, E.N.; Gisina, O.G.; Kalnitskaya, O.V. 2021: The trends and perspectives of development of medical tourism. Problemy Sotsial'noi Gigieny Zdravookhraneniia i Istorii Meditsiny 29(2): 206-212

Zeng, J.; Zhang, Q. 2020: The trends in land surface heat fluxes over global monsoon domains and their responses to monsoon and precipitation. Scientific Reports 10(1): 5762

Takemura, A.; Ito, K. 2020: The trends in predicting drug-induced liver injury. Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 155(6): 401-405

Luo, Z.; Hu, S.; Chen, D. 2018: The trends of aquacultural nitrogen budget and its environmental implications in China. Scientific Reports 8(1): 10877

Iftikhar, S.; Jahanzeb, N.; Saleem, M.; Ur Rehman, S.; Matinlinna, J.P.; Khan, A.S. 2021: The trends of dental biomaterials research and future directions: a mapping review. Saudi Dental Journal 33(5): 229-238

Pupić-Bakrač, A.; Pupić-Bakrač, J.; Jurković, D.; Capar, M.; Lazarić Stefanović, L.; Antunović Ćelović, I.; Kučinar, J.; Polkinghorne, A.; Beck, R. 2020: The trends of human dirofilariasis in Croatia: Yesterday - Today - Tomorrow. One Health 10: 100153

Alshabibi, M.; Madkhali, A.M.; Alkinani, A.A.; Alyami, A.A.; Alatassi, A. 2021: The trends of obstetric anesthesia practice: in a tertiary care center in the Kingdom of Saudi Arabia. Saudi Journal of Anaesthesia 15(4): 383-386

Asabu, M.D.; Altaseb, D.K. 2021: The trends of women's autonomy in health care decision making and associated factors in Ethiopia: evidence from 2005, 2011 and 2016 DHS data. Bmc Women's Health 21(1): 371

Terracol, J.; Gros, C. 1949: The trepidation of the optical channels in severe acute papillitis. Revue d'Oto-Neuro-Ophtalmologie 21(4): 230-232

Barnett, C.W. 1951: The treponemal immobilization test in the diagnosis of syphilis. Stanford Medical Bulletin 9(4): 205-206

Leroux, L.; Lemoyne, J.; Borst, M. 1948: The trepuncture of the frontal sinus; indications and results. Les Annales d'Oto-Laryngologie 65(12): 800-803

Ellwanger, J.H.; Chies, J.é A.B. 2019: The triad "dogs, conservation and zoonotic diseases" - An old and still neglected problem in Brazil. Perspectives in Ecology and Conservation 17(3): 157-161

Pullerits, T.; Rönmark, E.P.; Ekerljung, L.; Palmqvist, M.A.; Arvidsson, M.; Mincheva, R.; Backman, H.; Kankaanranta, H.; Ilmarinen, P.; Rådinger, M.; Lundbäck, B.; Nwaru, B.I. 2021: The triad of current asthma, rhinitis and eczema is uncommon among adults: Prevalence, sensitization profiles, and risk factors. Respiratory Medicine 176: 106250

Imbona, J.M. 1947: The trial of German doctors. Le Medecin Generaliste de France 7(23): 346-349

Bour, H. 1950: The trial of induced galactosuria and renal damage. Revue de Pathologie Comparee 50(614): 8-21

Dong, D.X.; Lian, Y.H.; Chen, T.Q.; Li, J.; Liang, W.S.; Cao, Y.Y.; Mao, J.S.; Chen, N.L.; Chai, S.A.; Huang, H.Y. 1988: The trial preparation of attenuated live hepatitis a vaccine. Proceedings of the Chinese Academy of Medical Sciences and the Peking Union Medical College 3(4): 199-202

Loizeau, A.J.; D'Agata, E.M.C.; Shaffer, M.L.; Hanson, L.C.; Anderson, R.A.; Tsai, T.; Habtemariam, D.A.; Bergman, E.H.; Carroll, R.P.; Cohen, S.M.; Scott, E.M.E.; Stevens, E.; Whyman, J.D.; Bennert, E.H.; Mitchell, S.L. 2019: The trial to reduce antimicrobial use in nursing home residents with Alzheimer's disease and other dementias: study protocol for a cluster randomized controlled trial. Trials 20(1): 594

Hege, K. 2019: The trials and tribulations of CAR-T cell development for cancer and AIDS. Nature Medicine 25(8): 1183

Klein, K.R.; Buse, J.B. 2020: The trials and tribulations of determining HbA 1c targets for diabetes mellitus. Nature Reviews. Endocrinology 16(12): 717-730

Johnson, I.S. 2003: The trials and tribulations of producing the first genetically engineered drug. Nature Reviews. Drug Discovery 2(9): 747-751

Ditlea, S. 2002: The trials of an artificial heart. Scientific American 287(1): 60-69

Vach, P.J.; Faivre, D. 2015: The triathlon of magnetic actuation: rolling, propelling, swimming with a single magnetic material. Scientific Reports 5: 9364

Dewhurst, K.E. 1949: The tribal distribution of bilharzia in East Africa. East African Medical Journal 26(4): 90-92

Shaw, D.; Naimi-Akbar, A.; Astvaldsdottir, A. 2015: The tribulations of toothpaste trials: Unethical arginine dentifrice research. British Dental Journal 219(12): 567-569

Massey, V.; Rogers, W.P. 1949: The tricarboxylic acid cycle in nematode parasites. Nature 163(4154): 909

Pashayan, H.M.; Solomon, L.M.; Chan, G. 1974: The tricho-rhino-phalangeal syndrome. American Journal of Diseases of Children 127(2): 257-261

Fontaine, G.; Maroteaux, P.; Farriaux, J.P.; Richard, J.; Roelens, B. 1970: The tricho-rhino-phalangeal syndrome. Archives Francaises de Pediatrie 27(6): 635-647

Kittsteiner, W. 1946: The trichomonas urethritis of men. Deutsche Medizinische Wochenschrift 71(13-16): 135

Wu, Q.; Guo, D.; Jia, H.; Nepovimova, E.; Wu, W.; Kuca, K. 2021: The trichothecene neosolaniol stimulates an emetic response through neuropeptide Y2 and serotonin 3 receptors in mink. Toxicology 452: 152718

Callaway, E. 2017: The trickiest family tree in biology. Nature 547(7661): 20-22

Maia, F.R.N.C.; Hajdu, J. 2016: The trickle before the torrent-diffraction data from X-ray lasers. Scientific Data 3: 160059

Watson, T. 2019: The trickster microbes that are shaking up the tree of life. Nature 569(7756): 322-324

Du, Y.; Wang, B.; Cai, Z.; Zhang, H.; Wang, B.; Liang, W.; Zhou, G.; Ouyang, F.; Wang, W. 2021: The triclosan-induced shift from aerobic to anaerobic metabolism link to increased steroidogenesis in human ovarian granulosa cells. Ecotoxicology and Environmental Safety 220: 112389

Werneck, F.L. 1945: The tricodectidoes of rodents (Mallophaga). Memorias do Instituto Oswaldo Cruz 42: 85-150

Cavaliere, F.; Fornarelli, A.; Bertan, F.; Russo, R.; Marsal-Cots, Aïs.; Morrone, L.Antonio.; Adornetto, A.; Corasaniti, M.Tiziana.; Bano, D.; Bagetta, G.; Nicotera, P. 2019: The tricyclic antidepressant clomipramine inhibits neuronal autophagic flux. Scientific Reports 9(1): 4881

Bann, S.J.; Ballantine, R.D.; Cochrane, S.A. 2021: The tridecaptins: non-ribosomal peptides that selectively target Gram-negative bacteria. Rsc Medicinal Chemistry 12(4): 538-551

Bonduelle, M. 1949: The tridione; specific medication for epilepticus. Paris Medical 2(2): 51-54

Ferner, H. 1949: The trigeminal cistern and its practical importance for the alcohol injection into the Gasser ganglion. Der Nervenarzt 20(1): 26-29

Khalifa, G.A.; Abd-Elmoniem, M.F.; Mohamed, F.I. 2021: The trigeminocardiac reflex: Does the activation pathway of its efferent arc affect the intensity of the hemodynamic drop during the management of maxillofacial fractures?. Journal of Cranio-Maxillo-Facial Surgery: Official Publication of the European Association for Cranio-Maxillo-Facial Surgery 49(5): 394-402

Vereecken, E. 1949: The trigger points of the shoulder girdle muscles in the brachialgia. RevueduRhumatismeetdesMaladiesOsteo-Articulaires 16(2): 60

Wiegand, U.K.; Corbach, S.; Prescott, A.R.; Savill, J.; Spruce, B.A. 2001: The trigger to cell death determines the efficiency with which dying cells are cleared by neighbours. Cell Death and Differentiation 8(7): 734-746

Dehkan, E. 1948: The triggering causes of lipoid neurosis. Gazette Medicale de France 55(13): 503-505

Cañas, C.A. 2020: The triggering of post-COVID-19 autoimmunity phenomena could be associated with both transient immunosuppression and an inappropriate form of immune reconstitution in susceptible individuals. Medical Hypotheses 145: 110345

Hong, S.; Han, K.; Park, C.-Y. 2020: The triglyceride glucose index is a simple and low-cost marker associated with atherosclerotic cardiovascular disease: a population-based study. Bmc Medicine 18(1): 361

Park, H.M.; Lee, H.S.; Lee, Y.-J.; Lee, J.-H. 2021: The triglyceride-glucose index is a more powerful surrogate marker for predicting the prevalence and incidence of type 2 diabetes mellitus than the homeostatic model assessment of insulin resistance. Diabetes Research and Clinical Practice 180: 109042

Duran Karaduman, B.; Ayhan, H.üs.; Keleş, T.; Bozkurt, E. 2020: The triglyceride-glucose index predicts peripheral artery disease complexity. Turkish Journal of Medical Sciences 50(5): 1217-1222

Peng, Y.; Chen, G.; Zheng, H. 2020: The triglyceride-lowering effects of PCSK9 inhibitor differ in patients with different baseline triglyceride levels. Nan Fang Yi Ke da Xue Xue Bao 40(8): 1141-1147

Sánchez-Escudero, V.ón.; García Lacalle, C.ón.; González Vergaz, A.; Mateo, L.R.; Marqués Cabrero, A. 2021: The triglyceride/glucose index as an insulin resistance marker in the pediatric population and its relation to eating habits and physical activity. Endocrinologia Diabetes y Nutricion 68(5): 296-303

Anoop, S.; Jebasingh, F.K.; Rebekah, G.; Kurian, M.Edatharayil.; Mohan, V.R.; Finney, G.; Thomas, N. 2020: The triglyceride/glucose ratio is a reliable index of fasting insulin resistance: Observations from hyperinsulinaemic-euglycaemic clamp studies in young, normoglycaemic males from southern India. Diabetes and Metabolic Syndrome 14(6): 1719-1723

Simental-Mendía, L.E.; Hernández-Ronquillo, G.; Gómez-Díaz, R.; Rodríguez-Morán, M.; Guerrero-Romero, F. 2017: The triglycerides and glucose index is associated with cardiovascular risk factors in normal-weight children and adolescents. Pediatric Research 82(6): 920-925

Ferreira, M.R.; Dantas, J.M.; Salgueiro, C.A. 2018: The triheme cytochrome PpcF from Geobacter metallireducens exhibits distinct redox properties. Febs Open Bio 8(12): 1897-1910

Bret, J. 1956: The trilogy of Fallot extreme trilogy of Fallot with atresia of the pulmonary orifice and persistence of the arterial channel. Archives des Maladies du Coeur et des Vaisseaux 49(4): 337-345

Serrano, A.; Sebastián, Mía.; Arilla-Luna, S.; Baquedano, S.; Herguedas, B.; Velázquez-Campoy, Aán.; Martínez-Júlvez, M.; Medina, M. 2017: The trimer interface in the quaternary structure of the bifunctional prokaryotic FAD synthetase from Corynebacterium ammoniagenes. Scientific Reports 7(1): 404

Daub, H.; Traxler, L.; Ismajli, F.; Groitl, B.; Itzen, A.; Rant, U. 2020: The trimer to monomer transition of Tumor Necrosis Factor-Alpha is a dynamic process that is significantly altered by therapeutic antibodies. Scientific Reports 10(1): 9265

Christiansen, A.; Weiel, M.; Winkler, A.; Schug, A.; Reinstein, J. 2021: The Trimeric Major Capsid Protein of Mavirus is stabilized by its Interlocked N-termini Enabling Core Flexibility for Capsid Assembly. Journal of Molecular Biology 433(7): 166859

Yamasaki, K.; Yamasaki, T.; Tateno, H. 2018: The trimeric solution structure and fucose-binding mechanism of the core fucosylation-specific lectin PhoSL. Scientific Reports 8(1): 7740

Tay, M.Zirui.; Poh, C.Meng.; Rénia, L.; MacAry, P.A.; Ng, L.F.P. 2020: The trinity of COVID-19: immunity, inflammation and intervention. Nature Reviews. Immunology 20(6): 363-374

Lowery, L.Anne.; Van Vactor, D. 2009: The trip of the tip: understanding the growth cone machinery. Nature Reviews. Molecular Cell Biology 10(5): 332-343

Lalo, U.; Koh, W.; Lee, C.J.; Pankratov, Y. 2021: The tripartite glutamatergic synapse. Neuropharmacology 199: 108758

Waseem, D.; Khan, G.Majid.; Haq, I-Ul.; Rashid, U.; Syed, D.N. 2020: The triphenyltin carboxylate derivative triphenylstannyl 2-(benzylcarbamoyl)benzoate impedes prostate cancer progression via modulation of Akt/FOXO3a signaling. Toxicology and Applied Pharmacology 401: 115091

Dorsey, E.R.; Kieburtz, K. 2021: The triple aim of clinical research. Clinical Trials 18(4): 511-513

Jung, M.; Jembere, G.B.; Park, Y.S.; Muhwava, W.; Choi, Y.; Cho, Y.; Ko, W. 2021: The triple burden of communicable and non-communicable diseases and injuries on sex differences in life expectancy in Ethiopia. International Journal for Equity in Health 20(1): 180

Peixoto, S.ér.V. 2020: The triple burden of health problems and the challenges for the Unified Health System. Ciencia and Saude Coletiva 25(8): 2912

Gonzalo, J.D.; Dekhtyar, M.; Caverzagie, K.J.; Grant, B.K.; Herrine, S.K.; Nussbaum, A.M.; Tad-Y, D.; White, E.; Wolpaw, D.R. 2021: The triple helix of clinical, research, and education missions in academic health centers: a qualitative study of diverse stakeholder perspectives. Learning Health Systems 5(4): E10250

Cornet, E. 1945: The triple peripheral iridectomy. Annales d'Oculistique 178: 531

Shakya, A.; Garje, V.; Rathore, A. 2021: The triple technique: a simple and effective outpatient procedure for the dorsal wrist ganglion. Journal of Clinical Orthopaedics and Trauma 23: 101619

Hashimoto, D.; Satoi, S.; Yamamoto, T.; Yamaki, S.; Hirooka, S.; Sakaguchi, T.; Sekimoto, M. 2021: The triple-checked criteria for drain management after pancreatectomy. AnnalsofHepato-Biliary-PancreaticSurgery 25(Suppl.1):S86

Trincas, M. 1958: The tripod of health: heredity, environment and nutrition. Minerva Medica 49(35): 1657-1659

Bonometti, A. 2020: The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification. Leukemia and Lymphoma 2020: 1-13

Na, T-Young.; Kim, G-Hwan.; Oh, H-Jeong.; Lee, M-Ho.; Han, Y-Hyun.; Kim, K.Taek.; Kim, J-Su.; Kim, D-Duk.; Lee, M-Ock. 2017: The trisaccharide raffinose modulates epidermal differentiation through activation of liver X receptor. Scientific Reports 7: 43823

Riser; Lavitry; Ribaut 1948: The trismus during protuberance tumors. L'Oto-Rhino-LaryngologieInternationale 32(3): 58

Sangweni, N.F.; Mosa, R.A.; Dludla, P.V.; Kappo, A.P.; Opoku, A.R.; Muller, C.J.F.; Johnson, R. 2021: The triterpene, methyl-3β-hydroxylanosta-9,24-dien-21-oate (RA3), attenuates high glucose-induced oxidative damage and apoptosis by improving energy metabolism. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 85: 153546

Xu, D.; Chen, L.; Chen, X.; Wen, Y.; Yu, C.; Yao, J.; Wu, H.; Wang, X.; Xia, Q.; Kong, X. 2017: The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy. Cell Death and Disease 8(8): E2983

Xie, Z.; Jiang, H.; Liu, W.; Zhang, X.; Chen, D.; Sun, S.; Zhou, C.; Liu, J.; Bao, S.; Wang, X.; Zhang, Y.; Li, J.; Hu, L.; Li, J. 2020: The triterpenoid sapogenin (2α-OH-Protopanoxadiol) ameliorates metabolic syndrome via the intestinal FXR/GLP-1 axis through gut microbiota remodelling. Cell Death and Disease 11(9): 770

Naß, J.; Abdelfatah, S.; Efferth, T. 2021: The triterpenoid ursolic acid ameliorates stress in Caenorhabditis elegans by affecting the depression-associated genes skn-1 and prdx2. Phytomedicine: International Journal of PhytoTherapy and Phytopharmacology 88: 153598

Eissenberg, J.C.; Lee, M.Gyu.; Schneider, J.; Ilvarsonn, A.; Shiekhattar, R.; Shilatifard, A. 2007: The trithorax-group gene in Drosophila little imaginal discs encodes a trimethylated histone H3 Lys4 demethylase. Nature Structural and Molecular Biology 14(4): 344-346

Lee, N.; Zhang, J.; Klose, R.J.; Erdjument-Bromage, H.; Tempst, P.; Jones, R.S.; Zhang, Y. 2007: The trithorax-group protein Lid is a histone H3 trimethyl-Lys4 demethylase. Nature Structural and Molecular Biology 14(4): 341-343

Stix, G. 2001: The triumph of the light. Scientific American 284(1): 80-86

Attiq, A.; Yao, L.J.; Afzal, S.; Khan, M.A. 2021: The triumvirate of NF-κB, inflammation and cytokine storm in COVID-19. International Immunopharmacology 101(Part B): 108255

Hoffmann, R. 1945: The trochanteric splint in war surgery. Helvetica Chirurgica Acta 12(1-2): 125-133

Borukhov, I.; Esposito, C.I.; Ismailidis, P.; LiArno, S.; Lyon, J.P.; McCarthy, T.F.; McEwen, P. 2023: The trochlear sulcus of the native knee is consistently orientated close to the sagittal plane despite variation in distal condylar anatomy. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 31(9): 3618-3626

Misselbrook, D. 2021: The trolley problem, 2021 style. British Journal of General Practice: the Journal of the Royal College of General Practitioners 71(703): 75

Crosnier, R. 1949: The troop's food. Annales d'Hygiene Publique Industrielle et Sociale 27(1): 2; Passim

Branch, T.A.; Watson, R.; Fulton, E.A.; Jennings, S.; McGilliard, C.R.; Pablico, G.T.; Ricard, D.; Tracey, S.R. 2010: The trophic fingerprint of marine fisheries. Nature 468(7322): 431-435

Ferreira, L.C.; Thums, M.; Heithaus, M.R.; Barnett, A.; Abrantes, Kátya.G.; Holmes, B.J.; Zamora, L.M.; Frisch, A.J.; Pepperell, J.G.; Burkholder, D.; Vaudo, J.; Nowicki, R.; Meeuwig, J.; Meekan, M.G. 2017: The trophic role of a large marine predator, the tiger shark Galeocerdo cuvier. Scientific Reports 7(1): 7641

Guilbert, L.; Robertson, S.A.; Wegmann, T.G. 1993: The trophoblast as an integral component of a macrophage-cytokine network. Immunology and Cell Biology 71: 49-57

Guleria, I.; Pollard, J.W. 2000: The trophoblast is a component of the innate immune system during pregnancy. Nature Medicine 6(5): 589-593

Devlin, M.J.; Lyons, B.P.; Johnson, J.E.; Hills, J.M. 2021: The tropical Pacific Oceanscape: Current issues, solutions and future possibilities. Marine Pollution Bulletin 166: 112181

Curasson, G. 1948: The tropical climate and animal production. Acta Tropica 5(2): 97-134

Mitchard, E.T.A. 2018: The tropical forest carbon cycle and climate change. Nature 559(7715): 527-534

Han, T.N. 1948: The tropical liver abscess. Medisch Maandblad 43(25): 504-508

Saint-Etienne, J. 1948: The tropical sprue; pathogenic considerations. Medecine Tropicale: Revue du Corps de Sante Colonial 8(5): 571-586

Ashton, P.; Zhu, H. 2020: The tropical-subtropical evergreen forest transition in East Asia: An exploration. Plant Diversity 42(4): 255-280

Sandegard, E. 1948: The trouble after spinal anesthesia. Nordisk Medicin 38(14): 687-694

Örstan, A. 2020: The trouble with Adineta vaga (Davis, 1873): a common rotifer that cannot be identified (Rotifera: Bdelloidea: Adinetidae). Zootaxa 4830(3)

Perrotta, M.; Geampana, A. 2020: The trouble with IVF and randomised control trials: Professional legitimation narratives on time-lapse imaging and evidence-informed care. Social Science and Medicine 258: 113115

Leys, R. 2021: The trouble with affect. History of Psychology 24(2): 126-129

Viguié, C.; Zalko, D. 2020: The trouble with endocrine disruptors. Molecular and Cellular Endocrinology 513: 110874

Frantz, S. 2006: The trouble with making combination drugs. Nature Reviews. Drug Discovery 5(11): 881-882

Grytaas, M.A.; Breivik, L.; Jørgensen, A.P.øm.; Finnes, T.E.; Skavlan, L.A.D.; Wiik, R.; Johansen, K.I.; Husebye, E.S. 2020: The trouble with medical coding. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 140(14)

Biello, D. 2007: The trouble with men. Scientific American 297(4): 104 106-7

Vousden, M. 1983: The trouble with nurses. Xianggang Hu Li Za Zhi. Hong Kong Nursing Journal 35: 42-43

Watkins, S.J. 1992: The trouble with nursing. Health Visitor 65(10): 334

Sondergaard, R.E.; Strzalkowski, N.D.J.; Kiss, Z.H.T.; Martino, D. 2021: The trouble with plasticity: Botulinum toxin, motor maps and focal hand dystonia. Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology 132(9): 2208-2210

Giles, J. 2006: The trouble with replication. Nature 442(7101): 344-347

Patterson, M. 2000: The trouble with smoking. Nature Reviews. Genetics 1(3): 168

McWilliams, B.J. 1982: The trouble with speech pathology. Cleft Palate Journal 19(4): 281-285

Newbold, T. 2019: The trouble with trade. Nature Ecology and Evolution 3(4): 522-523

Sinclair, N.R. 1995: The trouble with transgenic mice. Immunology and Cell Biology 73(2): 169-173

Elgar, F.J.; Stefaniak, A.; Wohl, M.J.A. 2020: The trouble with trust: Time-series analysis of social capital, income inequality, and COVID-19 deaths in 84 countries. Social Science and Medicine 263: 113365

Niiler, E. 2001: The trouble with turtles. Scientific American 285(2): 80-85

Coste, J.; Bizouarn, P.; Leplège, A. 2020: The troubled epistemology of the first wave of research on Covid-19. Revue d'Epidemiologie et de Sante Publique 68(5): 269-271

Bhat, C.; Goldszmidt, M. 2020: The troublesome nature of intraprofessional collaboration: a threshold concept perspective. Medical Education 54(12): 1088-1090

Goel, A.; Dave, N.; Shah, H.; Muneshwar, P. 2020: The troublesome triumvirate: Temporomandibular joint ankylosis, Pierre Robin syndrome and severe obstructive sleep apnoea. Indian Journal of Anaesthesia 64(9): 800-803

Cioffi, G.; Viapiana, O.; Tarantini, L.; Orsolini, G.; Idolazzi, L.; Ognibeni, F.; Dalbeni, A.; Gatti, D.; Fassio, A.; Adami, G.; Rossini, M.; Giollo, A. 2021: The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases. Arthritis Research and Therapy 23(1): 89

Rieux, M.; Alpaugh, M.; Cicchetti, F. 2019: The troubling story of blood-driven dementias. Molecular Psychiatry 24(2): 162-166

Ellis, H. 2021: The trousers' trap: an unusual injury that changed history. Journal of Perioperative Practice 31(5): 199-200

Gins, H.A. 1948: The true Nature of the Siphonospora. Zahnarztliche Welt 3(11): 285-287

Dambroise, R. 1947: The true albumen in centrosperms of the chenopodic type. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 224(15): 1120

Jassim, S.S.; Clough, R.; Yarashi, T.; Carlos, A.; Di Mascio, L. 2021: The true axial shoulder projection: Diagnostic aid for acromioclavicular joint dislocation?. Shoulder and Elbow 13(3): 290-295

Mathieu, Ér.; Pavlović, M.; Skejo, J. 2021: The true colours of the Formidable Pygmy Grasshopper (Notocerus formidabilis Günther, 1974) from the Sava region (Madagascar). Zookeys 1042: 41-50

Sasaki, H.M.; Tomari, Y. 2012: The true core of RNA silencing revealed. Nature Structural and Molecular Biology 19(7): 657-660

Inman, M. 2013: The true cost of fossil fuels. Scientific American 308(4): 58-61

Marson, P.; Cozza, A.; De Silvestro, G. 2020: The true historical origin of convalescent plasma therapy. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 59(5): 102847

Silva-Oliveira, C.ár.; Moreira, C.R.; Lima, F.áv.C.T.; Py-Daniel, L.úc.R. 2020: The true identity of Bryconops cyrtogaster (Norman), and description of a new species of Bryconops Kner (Characiformes: Iguanodectidae) from the Rio Jari, lower Amazon basin. Journal of Fish Biology 97(3): 860-868

Zawadzki, J.M.; Zimmer, K.; Przywara, W.; Zyśko, D.; Radziejewska, J.; Sławuta, A.; Gajek, J. 2020: The true nature of P wave dispersion. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 29(12): 1443-1447

Marin Amat, M. 1949: The true role of fistulizing operations in the treatment of glaucoma. Archivos de la Sociedad Oftalmologica Hispano-Americana 8(12): 1249-1254

Airola, V.R. 1985: The true role of physicians. Western Journal of Medicine 142(6): 836

Lim, J.Y.; Marshall, C.R. 2017: The true tempo of evolutionary radiation and decline revealed on the Hawaiian archipelago. Nature 543(7647): 710-713

Koester, K.J.; Ager, J.W.; Ritchie, R.O. 2008: The true toughness of human cortical bone measured with realistically short cracks. Nature Materials 7(8): 672-677

Williams, G. 2020: The true worth of a nurse … time to act!. Journal of Advanced Nursing 76(10): 2469-2470

Wang, W.; Liu, N.; Gao, C.; Rui, L.; Jiang, Q.; Chen, S.; Zhang, Q.; Zhong, G.; Tang, D. 2021: The truncated TNL receptor TN2-mediated immune responses require ADR1 function. Plant Journal: for Cell and Molecular Biology 108(3): 672-689

Hou, J.; Liu, H.-Y.; Diao, H.; Yu, H. 2021: The truncated human beta-defensin 118 can modulate lipopolysaccharide mediated inflammatory response in RAW264.7 macrophages. Peptides 136: 170438

Carvalho, D.d.S.; Ocarino, J.M.; Cruz, A.d.C.; Barsante, L.D.; Teixeira, B.G.ça.; Resende, R.A.; Fonseca, S.ér.T.; Souza, T.R. 2021: The trunk is exploited for energy transfers of maximal instep soccer kick: a power flow study. Journal of Biomechanics 121: 110425

Margaria, R. 1948: The trunk of the brain as a regulator of the central nervous system. Archivio di Scienze Biologiche 32(4): 269-277

Duchene, Y.; Mornieux, G.; Petel, A.; Perrin, P.P.; Gauchard, G.ér.C. 2021: The trunk's contribution to postural control under challenging balance conditions. Gait and Posture 84: 102-107

Birch, M.; van Bergen, L. 2021: The trust deficit: pandemic, disarmament, climate change and the securitization of health. Medicine Conflict and Survival 37(3): 173-176

Eneli, I.U.; Crum, P.A.; Tylka, T.L. 2008: The trust model: a different feeding paradigm for managing childhood obesity. Obesity 16(10): 2197-2204

Dixon, P. 1994: The truth about AIDS. Nature 367(6461): 311

Rosenfeld, G.; Bressler, B. 2012: The truth about cigarette smoking and the risk of inflammatory bowel disease. American Journal of Gastroenterology 107(9): 1407-1408

Hájek, M. 2002: The truth about devitalization. Vnitrni Lekarstvi 48(3): 175-176

Hájek, M. 2001: The truth about devitalization. Casopis Lekaru Ceskych 140(24): 774-775

Hecht, J. 2016: The truth about exoplanets. Nature 530(7590): 272-274

Christensen, M.G. 1998: The truth about fee guides. Journal 64(10): 698-699

Wadman, M. 2015: The truth about fetal tissue research. Nature 528(7581): 178-181

Mooney, C. 2011: The truth about fracking. Scientific American 305(5): 80-85

Knight, J. 2004: The truth about lying. Nature 428(6984): 692-694

The Lancet 2020: The truth is out there, somewhere. Lancet 396(10247): 291

Itoh, T. 2021: The truth lies somewhere in the middle: the cells responsible for liver tissue maintenance finally identified. Cell Regeneration 10(1): 28

Canet; Ducamp-Vignal; Quercy; Royère; Habivas; Brisacier 1974: The truth to the patient. Revue de l'Infirmiere 24(8): 735-736

Sutcliffe, J. 2021: The truth will out: a reflection on the life and times of Alice Stewart. International Journal of Radiation Biology 2021: 1-42

Von Willer, P. 1948: The trypan blue staining of the nervous system. Mikroskopie 3(3-4): 65-71

Pays, E.; Vanhollebeke, B.; Vanhamme, L.; Paturiaux-Hanocq, Fçoise.; Nolan, D.P.; Pérez-Morga, D. 2006: The trypanolytic factor of human serum. Nature Reviews. Microbiology 4(6): 477-486

Field, M.C.; Carrington, M. 2009: The trypanosome flagellar pocket. Nature Reviews. Microbiology 7(11): 775-786

Hemmati, S.A.; Takalloo, Z.; Taghdir, M.; Mehrabadi, M.; Balalaei, S.; Moharramipour, S.; H Sajedi, R. 2021: The trypsin inhibitor pro-peptide induces toxic effects in Indianmeal moth, Plodia interpunctella. Pesticide Biochemistry and Physiology 171: 104730

Hong, J.; Xin, S.; Min, R.; Zhang, Y.; Deng, Y. 2021: The tryptic peptides of hemoglobin for diagnosis of type 2 diabetes mellitus using label-free and standard-free LC-ESI-DMRM. Redox Biology 43: 101985

Lott, J.S. 2020: The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease. Biochemical Society Transactions 48(5): 2029-2037

Hyde, C.C.; Miles, E.W. 1990: The tryptophan synthase multienzyme complex: exploring structure-function relationships with X-ray crystallography and mutagenesis. Bio/Technology 8(1): 27-32

Dawes, E.A.; Happold, F.C. 1949: The tryptophanase-tryptophan reaction. 9. the nature, characteristics and partial purification of the tryptophanase complex. Biochemical Journal 44(3): 349-361

Gemmell, N.J.; Rutherford, K.; Prost, S.; Tollis, M.; Winter, D.; Macey, J.Robert.; Adelson, D.L.; Suh, A.; Bertozzi, T.; Grau, Jé.H.; Organ, C.; Gardner, P.P.; Muffato, M.; Patricio, M.; Billis, K.; Martin, F.J.; Flicek, P.; Petersen, B.; Kang, L.; Michalak, P.; Buckley, T.R.; Wilson, M.; Cheng, Y.; Miller, H.; Schott, R.K.; Jordan, M.D.; Newcomb, R.D.; Arroyo, Jé.Ignacio.; Valenzuela, N.; Hore, T.A.; Renart, J.; Peona, V.; Peart, C.R.; Warmuth, V.M.; Zeng, L.; Kortschak, R.Daniel.; Raison, J.M.; Zapata, V.Velásquez.; Wu, Z.; Santesmasses, D.; Mariotti, M.; Guigó, R 2020: The tuatara genome reveals ancient features of amniote evolution. Nature 584(7821): 403-409

Luis Oliva, J. 1963: The tubal factor in sterility. Toko-Ginecologia Practica 22: 32-46

Valstar, M.H.; de Bakker, B.S.; Steenbakkers, R.J.H.M.; de Jong, K.H.; Smit, L.A.; Klein Nulent, T.J.W.; van Es, R.J.J.; Hofland, I.; de Keizer, B.; Jasperse, B.; Balm, A.J.M.; van der Schaaf, A.; Langendijk, J.A.; Smeele, L.E.; Vogel, W.V. 2021: The tubarial salivary glands: a potential new organ at risk for radiotherapy. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 154: 292-298

Snieder, R. 2000: The tube worm turns. Nature 406(6799): 939

Roloff, W. 1948: The tubercle bacillus as the causative agent of human tuberculosis. Arztliche Wochenschrift 3(13-14): 210-214

Dvořák, J.; Šnajdr, M.; Šmrhová, D. 2021: The tubercle of Zuckerkandl, the ligament of Berry - importance for thyroid surgery. Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 100(3): 105-109

Wiese, O. 1947: The tubercular child and the acute infectious diseases. Der Tuberkulosearzt 1(2): 76-84

Canova, F. 1948: The tuberculin curireaction in a group of Basuto young people. Acta Medica Italica di Malattie Infettive e Parassitarie 3(5): 123-125

Masselot, I. 1947: The tuberculin cuti-reaction in young people in a factory environment. Le Medecin d'Usine; Revue d'Hygiene Industrielle et des Maladies Professionnelles 9(9-10): 315-319

Rapaport, Y. 1947: The tuberculin index among schoolchildren in the Paris suburbs. Semaine des Hopitaux: Informations 23(48): 2965

Martinelli, M. 1947: The tuberculin investigation as a means of social inquiry. Lotta Contro la Tubercolosi 17(2): 148-172

Freerksen, E. 1963: The tuberculin reaction and its diagnostic value for medical practice. Beitrage Zur Klinik der Tuberkulose und Spezifischen Tuberkulose-Forschung 127: 174-181

Oltramare, D. 1950: The tuberculin reaction; a new way of conceiving the mechanism. Pediatrie 5(1): 143-146

Martin, P. 1994: The tuberculin skin test. New Zealand Medical Journal 107(983): 310-311

Panarella, M.; Hampshire, V. 2016: The tuberculin skin test in monkeys. Lab Animal 45(9): 331-332

Montel, M.L. 1954: The tuberculoid form of leprosy (early form) in France and Cochinchina; classifications. International Journal of Leprosy 22(4): 403-408

Margarot, J.; Rimbaud, P.; Guilbert, H.L. 1948: The tuberculoid neuritis of leprosy. Annales de Dermatologie et de Syphiligraphie 8(4): 333-341

Tegtmeier, A. 1950: The tuberculologist and his duties; a word to the younger generation. Das Deutsche Gesundheitswesen 5(42): 1330-1333

Courtois, R.; De Winter, L. 1947: The tuberculose jéjuno-iléo-caecale. Acta Gastro-Enterologica Belgica 10(4): 163-271

Angirany, J. 1946: The tuberculosis dispensary and prophylaxis in the countryside. Concours Medical 68(52): 1625-1627

Edwards, R. 1949: The tuberculosis dispensary at the service of the medical practitioner. Journal des Praticiens; Revue Generale de Clinique et de Therapeutique 63(36): 440-442

Imaz, C.M. 1945: The tuberculosis family; economic situation and epidemiological environment. Archivos Uruguayos de Medicina Cirugia y Especialidades 27: 158-166

Hulst, L.A.; Zielstra, L.J. 1948: The tuberculosis issue among hospital staff. Het Ziekenhuiswezen 21(6): 165-168

Kupper, A. 1947: The tuberculosis mortality of the miners. Der Tuberkulosearzt 1(1): 44-46

Sun, J.; Siroy, A.; Lokareddy, R.K.; Speer, A.; Doornbos, K.S.; Cingolani, G.; Niederweis, M. 2015: The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD. Nature Structural and Molecular Biology 22(9): 672-678

Wissler, H.; Meier, H. 1947: The tuberculosis of school leavers. Schweizerische Medizinische Wochenschrift 77(52): 1349-1351

Poix, G.; Bernard, E. 1949: The tuberculosis placement crisis. La Presse Medicale 57(36): 505

Henschen, F. 1949: The tuberculosis problem in Sweden. Revista Medica de Cordoba 37(1): 1-20

Curry, F.J. 1968: The tuberculosis problem today. California Medicine 109(5): 418-420

Li, L.; Gao, J.T.; Du, J.; Tang, S.J.; Liu, Y.H. 2021: The tuberculosis sanitariums during era of the Republic of China. Zhonghua Yi Shi Za Zhi 51(2): 103-110

Mostyn, M. 1947: The tuberculosis service in Denmark. MAGAZINE. Royal Free Hospital . School of Medicine 9(22): 43-45

Hansen, O.G. 1955: The tuberculosis situation today. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 75(5): 151-157

Muntendam, P. 1946: The tuberculosis sterite in Europe. Tegen de Tuberculose 42(2): 7-9

Kleinschmidt, H. 1948: The tuberculosis vaccine according to Calmette; especially due to the experiences in Sweden. Deutsche Medizinische Wochenschrift 73(9-12): 105-109

Hirt, R.; Hurni, H. 1949: The tuberculostatic effect of p-aminosalicylic acid derivatives and similar substances. Helvetica Chimica Acta 32(2): 378-393

Hurni, H. 1949: The tuberculostatic effects of combinations of some well-known chemotherapeutic agents. Schweizerische Zeitschrift für Pathologie und Bakteriologie. Revue Suisse de Pathologie et de Bacteriologie 12(5): 596-601

Gravel, J.A.; Lou, W. 1956: The tuberculous bronchial stenosis and its surgical treatment. Laval Medical 21(9): 1237-1255

Macquet, P. 1945: The tuberculous kidney excluded; new aspect of the problem; therapeutic deductions. La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 21: 1331-1338

Solomides, J. 1945: The tuberculous olysis; mode of action of peanut oil. Revue de la Tuberculose 9(10): 211-213

Duarte G, I. 2021: The tuberculous world of Maxence van der Meersch. Revista Chilena de Infectologia: Organo Oficial de la Sociedad Chilena de Infectologia 38(3): 432-437

Shan, L.; Fronczek, R.; Lammers, G.J.; Swaab, D.F. 2021: The tuberomamillary nucleus in neuropsychiatric disorders. Handbook of Clinical Neurology 180: 389-400

Benvenuto, G.; Li, S.; Brown, S.J.; Braverman, R.; Vass, W.C.; Cheadle, J.P.; Halley, D.J.; Sampson, J.R.; Wienecke, R.; DeClue, J.E. 2000: The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination. Oncogene 19(54): 6306-6316

Vallon, V.; Thomson, S.C. 2020: The tubular hypothesis of nephron filtration and diabetic kidney disease. Nature Reviews. Nephrology 16(6): 317-336

Gregoir, W. 1955: The tubular plasty heavy pyrenees. Acta Urologica Belgica 23(3): 256-259

Dobrovolskaia-Zavadskaia, N.; Nekhorocheva, I. 1947: The tubulation phenomenon and other manifestations of cytolysis in mouse mammary adenocarcinomas. Comptes Rendus Hebdomadaires des Seances de l'Academie des Sciences 225(2): 156

Venkatachalam, M.A.; Weinberg, J.M. 2012: The tubule pathology of septic acute kidney injury: a neglected area of research comes of age. Kidney International 81(4): 338-340

Janke, C.; Magiera, M.M. 2020: The tubulin code and its role in controlling microtubule properties and functions. Nature Reviews. Molecular Cell Biology 21(6): 307-326

Anand, A.; Kai, T. 2012: The tudor domain protein kumo is required to assemble the nuage and to generate germline pi RNAs in Drosophila. EMBO Journal 31(4): 870-882

Messias, A.; Santos, D.E.S.; Pontes, F.J.S.; Soares, T.A. 2021: The tug of war between Al3+ and Na+ for order-disorder transitions in lipid-A membranes. Physical Chemistry Chemical Physics: Pccp 23(28): 15127-15137

Moawad, F.J.; Robinson, C.L.; Veerappan, G.R.; Summers, T.A.; Maydonovitch, C.L.; Wong, R.Kh. 2013: The tug sign: an endoscopic feature of eosinophilic esophagitis. American Journal of Gastroenterology 108(12): 1938-1939

Kuhn, H. 1947: The tumor as a shape disorder. Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 2(23-24): 716-722

Kozma, K.J.; Done, S.J.; Egan, S.E. 2021: The tumor cell-derived matrix of lobular breast cancer: a new vulnerability. EMBO molecular medicine 13(3): e13807

Bibus, B. 1948: The tumor diseases of the prostate in the light of recent hormone research. Wiener Klinische Wochenschrift 60(22): 345-349

Zheng, Y.; Bi, G.; Bian, Y.; Li, M.; Huang, Y.; Zhao, M.; Chen, Z.; Zhan, C.; Jiang, W. 2021: The tumor environment immune phenotype of LUSC by genome-wide analysis. International Immunopharmacology 96: 107564

Tod, B.M.; Schneider, J.W.; Bowcock, A.M.; Visser, W.I.; Kotze, M.J. 2020: The tumor genetics of acral melanoma: what should a dermatologist know?. Jaad International 1(2): 135-147

He, L.; Yang, H.; Huang, J. 2021: The tumor immune microenvironment and immune-related signature predict the chemotherapy response in patients with osteosarcoma. Bmc Cancer 21(1): 581

Gurin, D.; Slavik, M.; Hermanova, M.; Selingerova, I.; Kazda, T.; Hendrych, M.; Shatokhina, T.; Vesela, M. 2020: The tumor immune microenvironment and its implications for clinical outcome in patients with oropharyngeal squamous cell carcinoma. Journal of Oral Pathology and Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 49(9): 886-896

Tang, Y.-Q.; Chen, T.-F.; Zhang, Y.; Zhao, X.-C.; Zhang, Y.-Z.; Wang, G.-Q.; Huang, M.-L.; Cai, S.-L.; Zhao, J.; Wei, B.; Huang, J. 2020: The tumor immune microenvironment transcriptomic subtypes of colorectal cancer for prognosis and development of precise immunotherapy. Gastroenterology Report 8(5): 381-389

Kim, S.; Kim, A.; Shin, J-Yeon.; Seo, J-Sun. 2020: The tumor immune microenvironmental analysis of 2,033 transcriptomes across 7 cancer types. Scientific Reports 10(1): 9536

Barreiro, G.; Gaínza, F.J.; Cánovas, A.; Alonso, J.J.; Oñate, J.; Irurzun, J.; Alvarez, A.; Aguirre, C. 1996: The tumor lysis syndrome. Revista Clinica Espanola 196(5): 310-312

Whiteside, T.L. 2008: The tumor microenvironment and its role in promoting tumor growth. Oncogene 27(45): 5904-5912

Ostman, A. 2012: The tumor microenvironment controls drug sensitivity. Nature Medicine 18(9): 1332-1334

Lin, E.W.; Karakasheva, T.A.; Hicks, P.D.; Bass, A.J.; Rustgi, A.K. 2016: The tumor microenvironment in esophageal cancer. Oncogene 35(41): 5337-5349

Rosean, T.R.; Tompkins, V.S.; Olivier, A.K.; Sompallae, R.; Norian, L.A.; Morse, H.C.; Waldschmidt, T.J.; Janz, S. 2015: The tumor microenvironment is the main source of IL-6 for plasma cell tumor development in mice. Leukemia 29(1): 233-237

Kamal, Y.; Schmit, S.L.; Frost, H.R.; Amos, C.I. 2020: The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy. ImmunoTherapy 12(14): 1083-1100

Shain, K.H.; Dalton, W.S.; Tao, J. 2015: The tumor microenvironment shapes hallmarks of mature B-cell malignancies. Oncogene 34(36): 4673-4682

Fridman, W.H. 2020: The tumor microenvironment: Prognostic and theranostic impact. Recent advances and trends. Seminars in Immunology 48: 101416

Hwang, J.W.; Kim, Y.C.; Lee, H.Y.; Lee, K.J.; Kim, T.H.; Lee, S.H. 2021: The tumor necrosis factor family molecules LIGHT and lymphotoxins in sinus mucosa of patients with chronic rhinosinusitis with or without nasal polyps. Cytokine 148: 155594

Joffe, Y.T.; van der Merwe, L.; Evans, J.; Collins, M.; Lambert, E.V.; September, A.; Goedecke, J.H. 2012: The tumor necrosis factor-α gene -238G>A polymorphism, dietary fat intake, obesity risk and serum lipid concentrations in black and white South African women. European Journal of Clinical Nutrition 66(12): 1295-1302

Chang, J.Y.; Xia, W.; Shao, R.; Sorgi, F.; Hortobagyi, G.N.; Huang, L.; Hung, M.C. 1997: The tumor suppression activity of E1A in HER-2/neu-overexpressing breast cancer. Oncogene 14(5): 561-568

Wolf, A.M. 2021: The tumor suppression theory of aging. Mechanisms of Ageing and Development 200: 111583

Tan, B.; Xu, X.; Zhang, Q.; Yuan, Z.; Dong, J. 2022: The tumor suppressive role of TIMP3 in the human osteosarcoma cells. Journal of Orthopaedic Science: Official Journal of the Japanese Orthopaedic Association 27(3): 689-695

Wang, Y.; Wang, Z.; Joshi, B.H.; Puri, R.K.; Stultz, B.; Yuan, Q.; Bai, Y.; Zhou, P.; Yuan, Z.; Hursh, D.A.; Bi, X. 2013: The tumor suppressor Caliban regulates DNA damage-induced apoptosis through p53-dependent and -independent activity. Oncogene 32(33): 3857-3866

Wu, H-Ta.; Xie, C-Rong.; Lv, J.; Qi, H-Qiang.; Wang, F.; Zhang, S.; Fang, Q-Liang.; Wang, F-Qiang.; Lu, Y-Yan.; Yin, Z-Yu. 2018: The tumor suppressor DLC1 inhibits cancer progression and oncogenic autophagy in hepatocellular carcinoma. Laboratory Investigation; a Journal of Technical Methods and Pathology 98(8): 1014-1024

Szczepny, A.; Carey, K.; McKenzie, L.; Jayasekara, W.Samantha.N.; Rossello, F.; Gonzalez-Rajal, A.; McCaw, A.S.; Popovski, D.; Wang, D.; Sadler, A.J.; Mahar, A.; Russell, P.A.; Wright, G.; McCloy, R.A.; Garama, D.J.; Gough, D.J.; Baylin, S.B.; Burgess, A.; Cain, J.E.; Watkins, D.Neil. 2018: The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53. Oncogene 37(14): 1939-1948

Chen, G.; Wang, Y.; Garate, M.; Zhou, J.; Li, G. 2010: The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system. Oncogene 29(10): 1498-1508

Ikeuchi, M.; Yuki, R.; Saito, Y.; Nakayama, Y. 2021: The tumor suppressor LATS2 reduces v-Src-induced membrane blebs in a kinase activity-independent manner. References 35(1): E21242

Mans, L.A.; Querol Cano, L.; van Pelt, J.; Giardoglou, P.; Keune, W-Jan.; Haramis, A-Pavlina.G. 2017: The tumor suppressor LKB1 regulates starvation-induced autophagy under systemic metabolic stress. Scientific Reports 7(1): 7327

Li, S.; Zhu, M.; Pan, R.; Fang, T.; Cao, Y-Yuan.; Chen, S.; Zhao, X.; Lei, C-Qi.; Guo, L.; Chen, Y.; Li, C-Mei.; Jokitalo, E.; Yin, Y.; Shu, H-Bing.; Guo, D. 2016: The tumor suppressor PTEN has a critical role in antiviral innate immunity. Nature Immunology 17(3): 241-249

Regad, T.; Bellodi, C.; Nicotera, P.; Salomoni, P. 2009: The tumor suppressor Pml regulates cell fate in the developing neocortex. Nature Neuroscience 12(2): 132-140

Richter, A.M.; Walesch, S.K.; Würl, P.; Taubert, H.; Dammann, R.H. 2012: The tumor suppressor RASSF10 is upregulated upon contact inhibition and frequently epigenetically silenced in cancer. Oncogenesis 1: E18

Srikantan, S.; Deng, Y.; Cheng, Z-Ming.; Luo, A.; Qin, Y.; Gao, Q.; Sande-Docor, G-Mae.; Tao, S.; Zhang, X.; Harper, N.; Shannon, C.E.; Fourcaudot, M.; Li, Z.; Kasinath, B.S.; Harrison, S.; Ahuja, S.; Reddick, R.L.; Dong, L.Q.; Abdul-Ghani, M.; Norton, L.; Aguiar, R.C.T.; Dahia, P.L.M. 2019: The tumor suppressor TMEM127 regulates insulin sensitivity in a tissue-specific manner. Nature Communications 10(1): 4720

Yang, K.; Neale, G.; Green, D.R.; He, W.; Chi, H. 2011: The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. Nature Immunology 12(9): 888-897

Kuninaka, S.; Nomura, M.; Hirota, T.; Iida, S-Ichi.; Hara, T.; Honda, S.; Kunitoku, N.; Sasayama, T.; Arima, Y.; Marumoto, T.; Koja, K.; Yonehara, S.; Saya, H. 2005: The tumor suppressor WARTS activates the Omi / HtrA2-dependent pathway of cell death. Oncogene 24(34): 5287-5298

Chan, S.L.; Cui, Y.; van Hasselt, A.; Li, H.; Srivastava, G.; Jin, H.; Ng, K.M.; Wang, Y.; Lee, K.Y.; Tsao, G.S.W.; Zhong, S.; Robertson, K.D.; Rha, S.Y.; Chan, A.T.C.; Tao, Q. 2007: The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas. Laboratory Investigation; a Journal of Technical Methods and Pathology 87(7): 644-650

Tao, C.; Luo, J.; Tang, J.; Zhou, D.; Feng, S.; Qiu, Z.; Putti, T.C.; Xiang, T.; Tao, Q.; Li, L.; Ren, G. 2020: The tumor suppressor Zinc finger protein 471 suppresses breast cancer growth and metastasis through inhibiting AKT and Wnt/β-catenin signaling. Clinical Epigenetics 12(1): 173

Marot, D.; Opolon, P.; Brailly-Tabard, S.; Elie, N.; Randrianarison, V.; Connault, E.; Foray, N.; Feunteun, J.; Perricaudet, M. 2006: The tumor suppressor activity induced by adenovirus-mediated BRCA1 overexpression is not restricted to breast cancers. Gene Therapy 13(3): 235-244

Rottapel, R.; Ilangumaran, S.; Neale, C.; La Rose, J.; Ho, J.M-Y.; Nguyen, M.H-H.; Barber, D.; Dubreuil, P.; de Sepulveda, P. 2002: The tumor suppressor activity of SOCS-1. Oncogene 21(28): 4351-4362

Cui, D.H.; Jiang, K.D.; Jiang, S.D.; Xu, Y.F.; Yao, H. 2005: The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia. Molecular Psychiatry 10(7): 669-677

Vedelek, V.; Kovács, A.L.; Juhász, Gábor.; Alzyoud, E.; Sinka, R. 2021: The tumor suppressor archipelago E3 ligase is required for spermatid differentiation in Drosophila testis. Scientific Reports 11(1): 8422

Boysen, J.; Sinha, S.; Price-Troska, T.; Warner, S.L.; Bearss, D.J.; Viswanatha, D.; Shanafelt, T.D.; Kay, N.E.; Ghosh, A.K. 2014: The tumor suppressor axis p53/miR-34a regulates Axl expression in B-cell chronic lymphocytic leukemia: implications for therapy in p53-defective CLL patients. Leukemia 28(2): 451-455

Chebotaev, D.; Yemelyanov, A.; Zhu, L.; Lavker, R.M.; Budunova, I. 2007: The tumor suppressor effect of the glucocorticoid receptor in skin is mediated via its effect on follicular epithelial stem cells. Oncogene 26(21): 3060-3068

Woodford, M.R.; Baker-Williams, A.J.; Sager, R.A.; Backe, S.J.; Blanden, A.R.; Hashmi, F.; Kancherla, P.; Gori, A.; Loiselle, D.R.; Castelli, M.; Serapian, S.A.; Colombo, G.; Haystead, T.A.; Jensen, S.M.; Stetler-Stevenson, W.G.; Loh, S.N.; Schmidt, L.S.; Linehan, W.Marston.; Bah, A.; Bourboulia, D.; Bratslavsky, G.; Mollapour, M. 2021: The tumor suppressor folliculin inhibits lactate dehydrogenase A and regulates the Warburg effect. Nature Structural and Molecular Biology 28(8): 662-670

Ong, H.T.; Tan, P.K.; Wang, S.M.; Hian Low, D.T.; Ooi, L.L.P.J.; Hui, K.M. 2011: The tumor suppressor function of LECT2 in human hepatocellular carcinoma makes it a potential therapeutic target. Cancer Gene Therapy 18(6): 399-406

Banerjee, R.; Mani, R-S.; Russo, N.; Scanlon, C.S.; Tsodikov, A.; Jing, X.; Cao, Q.; Palanisamy, N.; Metwally, T.; Inglehart, R.C.; Tomlins, S.; Bradford, C.; Carey, T.; Wolf, G.; Kalyana-Sundaram, S.; Chinnaiyan, A.M.; Varambally, S.; D'Silva, N.J. 2011: The tumor suppressor gene rap1GAP is silenced by miR-101-mediated EZH2 overexpression in invasive squamous cell carcinoma. Oncogene 30(42): 4339-4349

Beveridge, D.J.; Richardson, K.L.; Epis, M.R.; Brown, R.A.M.; Stuart, L.M.; Woo, A.J.; Leedman, P.J. 2021: The tumor suppressor miR-642a-5p targets Wilms Tumor 1 gene and cell-cycle progression in prostate cancer. Scientific Reports 11(1): 18003

Tristán-Ramos, P.; Rubio-Roldan, A.; Peris, G.; Sánchez, L.; Amador-Cubero, S.; Viollet, S.; Cristofari, G.; Heras, S.R. 2020: The tumor suppressor microRNA let-7 inhibits human LINE-1 retrotransposition. Nature Communications 11(1): 5712

Shapira, S.; Barkan, B.; Friedman, E.; Fridman, E.; Kloog, Y.; Stein, R. 2007: The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways. Cell Death and Differentiation 14(5): 895-906

Al-Mohanna, M.A.; Manogaran, P.S.; Al-Mukhalafi, Z.; A Al-Hussein, K.; Aboussekhra, A. 2004: The tumor suppressor p16(INK4a) gene is a regulator of apoptosis induced by ultraviolet light and cisplatin. Oncogene 23(1): 201-212

Bianchi, T.; Rufer, N.; MacDonald, H.R.; Migliaccio, M. 2006: The tumor suppressor p16Ink4a regulates T lymphocyte survival. Oncogene 25(29): 4110-4115

Balakrishnan, S.K.; Gross, D.S. 2008: The tumor suppressor p53 associates with gene coding regions and co-traverses with elongating RNA polymerase II in an in vivo model. Oncogene 27(19): 2661-2672

Middeler, G.; Zerf, K.; Jenovai, S.; Thulig, A.; Tschödrich-Rotter, M.; Kubitscheck, U.; Peters, R. 1997: The tumor suppressor p53 is subject to both nuclear import and export, and both are fast, energy-dependent and lectin-inhibited. Oncogene 14(12): 1407-1417

Janghorban, M.; Langer, E.M.; Wang, X.; Zachman, D.; Daniel, C.J.; Hooper, J.; Fleming, W.H.; Agarwal, A.; Sears, R.C. 2017: The tumor suppressor phosphatase PP2A-B56α regulates stemness and promotes the initiation of malignancies in a novel murine model. Plos one 12(11): E0188910

Perfettini, J-L.; Nardacci, R.; Séror, C.; Bourouba, M.; Subra, F.; Gros, L.; Manic, G.; Amendola, A.; Masdehors, P.; Rosselli, F.; Ojcius, D.M.; Auclair, C.; de Thé, H.; Gougeon, M-L.; Piacentini, M.; Kroemer, G. 2009: The tumor suppressor protein PML controls apoptosis induced by the HIV-1 envelope. Cell Death and Differentiation 16(2): 298-311

Heppner, C.; Bilimoria, K.Y.; Agarwal, S.K.; Kester, M.; Whitty, L.J.; Guru, S.C.; Chandrasekharappa, S.C.; Collins, F.S.; Spiegel, A.M.; Marx, S.J.; Burns, A.L. 2001: The tumor suppressor protein menin interacts with NF-kappaB proteins and inhibits NF-kappaB-mediated transactivation. Oncogene 20(36): 4917-4925

Di Giovanni, S.; Knights, C.D.; Rao, M.; Yakovlev, A.; Beers, J.; Catania, J.; Avantaggiati, M.Laura.; Faden, A.I. 2006: The tumor suppressor protein p53 is required for neurite outgrowth and axon regeneration. EMBO Journal 25(17): 4084-4096

Søe, K.; Hartmann, H.; Schlott, B.; Stevnsner, T.; Grosse, F. 2002: The tumor suppressor protein p53 stimulates the formation of the human topoisomerase I double cleavage complex in vitro. Oncogene 21(43): 6614-6623

Chomet, M.; Schreurs, M.; Nguyen, M.; Howng, B.; Villanueva, R.; Krimm, M.; Vasiljeva, O.; van Dongen, G.A.M.S.; Vugts, D.J. 2020: The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by 89Zr-immuno-PET in xenograft bearing mice. Theranostics 10(13): 5815-5828

Zhang, B.; Tang, C.; Yao, Y.; Chen, X.; Zhou, C.; Wei, Z.; Xing, F.; Chen, L.; Cai, X.; Zhang, Z.; Sun, S.; Liu, Q. 2021: The tumor therapy landscape of synthetic lethality. Nature Communications 12(1): 1275

Broberg, K.; Tallini, G.; Höglund, M.; Lindstrand, A.; Toksvig-Larsen, S.; Mertens, F. 2001: The tumor-associated gene HMGIC is expressed in normal and osteoarthritis-affected synovia. Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 14(4): 311-317

Gogl, H. 1948: The tumor-forming chronic inflammation of the areola (areolitis chronica). Wiener Medizinische Wochenschrift 98(3-4): 29-31

Peintner, L.; Dorstyn, L.; Kumar, S.; Aneichyk, T.; Villunger, A.; Manzl, C. 2015: The tumor-modulatory effects of Caspase-2 and Pidd1 do not require the scaffold protein Raidd. Cell Death and Differentiation 22(11): 1803-1811

Van Duuren, B.L.; Sivak, A.; Langseth, L. 1967: The tumor-promoting activity of tobacco leaf extract and whole cigarette tar. British Journal of Cancer 21(2): 460-463

Marcucci, F.; Rumio, C. 2021: The tumor-promoting effects of the adaptive immune system: a cause of hyperprogressive disease in cancer?. Cellular and Molecular Life Sciences: Cmls 78(3): 853-865

Luwor, R.B.; Zhu, H-Jian.; Walker, F.; Vitali, A.A.; Perera, R.M.; Burgess, A.W.; Scott, A.M.; Johns, T.G. 2004: The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR. Oncogene 23(36): 6095-6104

Yi, W.; Yu, Y.; Li, Y.; Yang, J.; Gao, S.; Xu, L. 2021: The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients. Bioengineered 12(1): 5323-5333

Kojima, S.; Enokida, H.; Yoshino, H.; Itesako, T.; Chiyomaru, T.; Kinoshita, T.; Fuse, M.; Nishikawa, R.; Goto, Y.; Naya, Y.; Nakagawa, M.; Seki, N. 2014: The tumor-suppressive microRNA-143/145 cluster inhibits cell migration and invasion by targeting GOLM1 in prostate cancer. Journal of Human Genetics 59(2): 78-87

Badgwell, D.B.; Lu, Z.; Le, K.; Gao, F.; Yang, M.; Suh, G.K.; Bao, J-J.; Das, P.; Andreeff, M.; Chen, W.; Yu, Y.; Ahmed, A.A.; S-L Liao, W.; Bast, R.C. 2012: The tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian cancer cell migration through inhibition of the Stat3 and FAK/Rho signaling pathways. Oncogene 31(1): 68-79

Zhang, Q.; Zhong, C.; Duan, S. 2021: The tumorigenic function of LINC00858 in cancer. Biomedicine and PharmacoTherapy 143: 112235

Ben-David, U.; Benvenisty, N. 2011: The tumorigenicity of human embryonic and induced pluripotent stem cells. Nature Reviews. Cancer 11(4): 268-277

Costessi, A.; Mahrour, N.; Tijchon, E.; Stunnenberg, R.; Stoel, M.A.; Jansen, P.W.; Sela, D.; Martin-Brown, S.; Washburn, M.P.; Florens, L.; Conaway, J.W.; Conaway, R.C.; Stunnenberg, H.G. 2011: The tumour antigen PRAME is a subunit of a Cul2 ubiquitin ligase and associates with active NFY promoters. EMBO Journal 30(18): 3786-3798

Gion, M.; Mione, R.; Nascimben, O.; Valsecchi, M.; Gatti, C.; Leon, A.; Bruscagnin, G. 1991: The tumour associated antigen CA15.3 in primary breast cancer. Evaluation of 667 cases. British Journal of Cancer 63(5): 809-813

RodrÍguez, E.; Schetters, S.T.T.; van Kooyk, Y. 2018: The tumour glyco-code as a novel immune checkpoint for immunotherapy. Nature Reviews. Immunology 18(3): 204-211

Barker, H.E.; Paget, J.T.E.; Khan, A.A.; Harrington, K.J. 2015: The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nature Reviews. Cancer 15(7): 409-425

Soncin, I.; Sheng, J.; Chen, Q.; Foo, S.; Duan, K.; Lum, J.; Poidinger, M.; Zolezzi, F.; Karjalainen, K.; Ruedl, C. 2018: The tumour microenvironment creates a niche for the self-renewal of tumour-promoting macrophages in colon adenoma. Nature Communications 9(1): 582

Laoui, D.; Keirsse, J.; Morias, Y.; Van Overmeire, E.; Geeraerts, X.; Elkrim, Y.; Kiss, M.; Bolli, E.; Lahmar, Q.; Sichien, D.; Serneels, J.; Scott, C.L.; Boon, L.; De Baetselier, P.; Mazzone, M.; Guilliams, M.; Van Ginderachter, J.A. 2016: The tumour microenvironment harbours ontogenically distinct dendritic cell populations with opposing effects on tumour immunity. Nature Communications 7: 13720

Scott, D.W.; Gascoyne, R.D. 2014: The tumour microenvironment in B cell lymphomas. Nature Reviews. Cancer 14(8): 517-534

Ho, W.Jin.; Jaffee, E.M.; Zheng, L. 2020: The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities. Nature Reviews. Clinical Oncology 17(9): 527-540

Marques, P.; Grossman, A.B.; Korbonits, M.ár. 2020: The tumour microenvironment of pituitary neuroendocrine tumours. Frontiers in Neuroendocrinology 58: 100852

Morrissey, M.E.; Byrne, R.ói.ín.; Nulty, C.; McCabe, N.H.; Lynam-Lennon, N.; Butler, C.T.; Kennedy, S.; O'Toole, D.; Larkin, J.; McCormick, P.; Mehigan, B.; Cathcart, M.-C.; Lysaght, J.; Reynolds, J.V.; Ryan, E.J.; Dunne, M.R.; O'Sullivan, J. 2020: The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. Bmc Cancer 20(1): 566

Di Blasio, S.; van Wigcheren, G.F.; Becker, A.; van Duffelen, A.; Gorris, M.; Verrijp, K.; Stefanini, I.; Bakker, G.J.; Bloemendal, M.; Halilovic, A.; Vasaturo, A.; Bakdash, G.; Hato, S.V.; de Wilt, J.H.W.; Schalkwijk, J.; de Vries, I.J.M.; Textor, J.C.; van den Bogaard, E.H.; Tazzari, M.; Figdor, C.G. 2020: The tumour microenvironment shapes dendritic cell plasticity in a human organotypic melanoma culture. Nature Communications 11(1): 2749

Luo, Y.; Yin, J.; Fang, R.; Liu, J.; Wang, L.; Zhang, H.; Zhang, M.; Lei, Z.; Liang, S.; Cui, W.; Zhang, Z.; Wu, K.; Hui, X. 2021: The tumour neovasculature-homing dimeric peptide GX1 demonstrates antiangiogenic activity in the retinal neovasculature. European Journal of Pharmacology 912: 174574

Dunstan, S.; Powe, D.G.; Wilkinson, M.; Pearson, J.; Hewitt, R.E. 1997: The tumour stroma of oral squamous cell carcinomas show increased vascularity compared with adjacent host tissue. British Journal of Cancer 75(4): 559-565

Miyakawa, K.; Nishi, M.; Matsunaga, S.; Okayama, A.; Anraku, M.; Kudoh, A.; Hirano, H.; Kimura, H.; Morikawa, Y.; Yamamoto, N.; Ono, A.; Ryo, A. 2017: The tumour suppressor APC promotes HIV-1 assembly via interaction with Gag precursor protein. Nature Communications 8: 14259

Balamurugan, K.; Wang, J-Ming.; Tsai, H-Hwa.; Sharan, S.; Anver, M.; Leighty, R.; Sterneck, E. 2010: The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis. EMBO Journal 29(24): 4106-4117

Kovalenko, A.; Chable-Bessia, C.; Cantarella, G.; Israël, A.; Wallach, D.; Courtois, G. 2003: The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature 424(6950): 801-805

Vitiello, E.; Ferreira, J.G.; Maiato, H.; Balda, M.S.; Matter, K. 2014: The tumour suppressor DLC2 ensures mitotic fidelity by coordinating spindle positioning and cell-cell adhesion. Nature Communications 5: 5826

Castillo-Lluva, S.; Tan, C-T.; Daugaard, M.; Sorensen, P.H.B.; Malliri, A. 2013: The tumour suppressor HACE1 controls cell migration by regulating Rac1 degradation. Oncogene 32(13): 1735-1742

Emoto, K.; Parrish, J.Z.; Jan, L.Yeh.; Jan, Y-Nung. 2006: The tumour suppressor Hippo acts with the NDR kinases in dendritic tiling and maintenance. Nature 443(7108): 210-213

Richter, C.; Oktaba, K.; Steinmann, J.; Müller, Jürg.; Knoblich, J.A. 2011: The tumour suppressor L(3)mbt inhibits neuroepithelial proliferation and acts on insulator elements. Nature Cell Biology 13(9): 1029-1039

Pooya, S.; Liu, X.; Kumar, V.B.Sameer.; Anderson, J.; Imai, F.; Zhang, W.; Ciraolo, G.; Ratner, N.; Setchell, K.D.R.; Yoshida, Y.; Yutaka, Y.; Jankowski, M.P.; Dasgupta, B. 2014: The tumour suppressor LKB1 regulates myelination through mitochondrial metabolism. Nature Communications 5: 4993

Song, M.Sup.; Song, S.Jung.; Kim, S.Yeon.; Oh, H.Jung.; Lim, D-Sik. 2008: The tumour suppressor RASSF1A promotes MDM2 self-ubiquitination by disrupting the MDM2-DAXX-HAUSP complex. EMBO Journal 27(13): 1863-1874

Song, M.Sup.; Song, S.Jeong.; Ayad, N.G.; Chang, J.Sook.; Lee, J.Hyun.; Hong, H.Kyung.; Lee, H.; Choi, N.; Kim, J.; Kim, H.; Kim, J.Woo.; Choi, E-Ju.; Kirschner, M.W.; Lim, D-Sik. 2004: The tumour suppressor RASSF1A regulates mitosis by inhibiting the APC-Cdc20 complex. Nature Cell Biology 6(2): 129-137

Climent-Cantó, P.; Carbonell, A.; Tamirisa, S.; Henn, L.; Pérez-Montero, S.; Boros, I.M.; Azorín, F. 2021: The tumour suppressor brain tumour (Brat) regulates linker histone dBigH1 expression in the Drosophila female germline and the early embryo. Open Biology 11(5): 200408

Hagman, Z.; Haflidadottir, B.S.; Ansari, M.; Persson, M.; Bjartell, A.; Edsjö, A.; Ceder, Y. 2013: The tumour suppressor miR-34c targets MET in prostate cancer cells. British Journal of Cancer 109(5): 1271-1278

Maxwell, P.H.; Wiesener, M.S.; Chang, G.W.; Clifford, S.C.; Vaux, E.C.; Cockman, M.E.; Wykoff, C.C.; Pugh, C.W.; Maher, E.R.; Ratcliffe, P.J. 1999: The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399(6733): 271-275

Chi, K.Rae. 2016: The tumour trail left in blood. Nature 532(7598): 269-271

McAllister, S.S.; Weinberg, R.A. 2014: The tumour-induced systemic environment as a critical regulator of cancer progression and metastasis. Nature Cell Biology 16(8): 717-727

Masuya, D.; Huang, C.; Liu, D.; Nakashima, T.; Kameyama, K.; Haba, R.; Ueno, M.; Yokomise, H. 2004: The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients. British Journal of Cancer 90(8): 1555-1562

Chaiwatanasirikul, K-A.; Sala, A. 2011: The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60. Cell Death and Disease 2: E219

Yoshino, H.; Chiyomaru, T.; Enokida, H.; Kawakami, K.; Tatarano, S.; Nishiyama, K.; Nohata, N.; Seki, N.; Nakagawa, M. 2011: The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. British Journal of Cancer 104(5): 808-818

Eyholzer, M.; Schmid, S.; Wilkens, L.; Mueller, B.U.; Pabst, T. 2010: The tumour-suppressive miR-29a/b1 cluster is regulated by CEBPA and blocked in human AML. British Journal of Cancer 103(2): 275-284

Dow, L.E.; Kauffman, J.S.; Caddy, J.; Zarbalis, K.; Peterson, A.S.; Jane, S.M.; Russell, S.M.; Humbert, P.O. 2007: The tumour-suppressor Scribble dictates cell polarity during directed epithelial migration: regulation of Rho GTPase recruitment to the leading edge. Oncogene 26(16): 2272-2282

Stone, D.M.; Hynes, M.; Armanini, M.; Swanson, T.A.; Gu, Q.; Johnson, R.L.; Scott, M.P.; Pennica, D.; Goddard, A.; Phillips, H.; Noll, M.; Hooper, J.E.; de Sauvage, F.; Rosenthal, A. 1996: The tumour-suppressor gene patched encodes a candidate receptor for Sonic hedgehog. Nature 384(6605): 129-134

Hamaratoglu, F.; Willecke, M.; Kango-Singh, M.; Nolo, R.; Hyun, E.; Tao, C.; Jafar-Nejad, H.; Halder, G. 2006: The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nature Cell Biology 8(1): 27-36

Peng, C.Y.; Manning, L.; Albertson, R.; Doe, C.Q. 2000: The tumour-suppressor genes lgl and dlg regulate basal protein targeting in Drosophila neuroblasts. Nature 408(6812): 596-600

Thornton, J.K.; Dalgleish, C.; Venables, J.P.; Sergeant, K.A.; Ehrmann, I.E.; Lu, X.; Saunders, P.T.K.; Elliott, D.J. 2006: The tumour-suppressor protein ASPP1 is nuclear in human germ cells and can modulate ratios of CD44 exon V5 spliced isoforms in vivo. Oncogene 25(22): 3104-3112

Willbold, M.; Elliott, T.; Moorbath, S. 2011: The tungsten isotopic composition of the Earth's mantle before the terminal bombardment. Nature 477(7363): 195-198

Brakman, S.; Garretsen, H.; van Witteloostuijn, A. 2020: The turn from just-in-time to just-in-case globalization in and after times of COVID-19: An essay on the risk re-appraisal of borders and buffers. Social Sciences and Humanities Open 2(1): 100034

Kendler, K.S.; Klee, A. 2020: The turn to controls and the refinement of the concept of hereditary burden: the 1895 study of Jenny Koller. American Journal of Medical Genetics. Part B Neuropsychiatric Genetics: the Official Publication of the International Society of Psychiatric Genetics 183(7): 433-442

Castro, M.; Ares, S.úl.; Cuesta, J.é A.; Manrubia, S. 2020: The turning point and end of an expanding epidemic cannot be precisely forecast. Proceedings of the National Academy of Sciences of the United States of America 117(42): 26190-26196

Ross, J. 1989: The turnover of messenger RNA. Scientific American 260(4): 48-55

Nalamalapu, R.R.; Yue, M.; Stone, A.R.; Murphy, S.; Saha, M.S. 2021: The tweety Gene Family: from Embryo to Disease. Frontiers in Molecular Neuroscience 14: 672511

Madersbacher, H. 1976: The twelve o'clock sphincterotomy: technique, indications, results. Paraplegia 13(4): 261-267

Cohen, P. 2006: The twentieth century struggle to decipher insulin signalling. Nature Reviews. Molecular Cell Biology 7(11): 867-873

Treydte, K.S.; Schleser, G.H.; Helle, G.; Frank, D.C.; Winiger, M.; Haug, G.H.; Esper, J. 2006: The twentieth century was the wettest period in northern Pakistan over the past millennium. Nature 440(7088): 1179-1182

Atkins, J.F.; Gesteland, R.F. 2000: The twenty-first amino acid. Nature 407(6803): 463 465

Nikolich-Žugich, J. 2018: The twilight of immunity: emerging concepts in aging of the immune system. Nature Immunology 19(1): 10-19

Feehan, J.; Tripodi, N.; Apostolopoulos, V. 2021: The twilight of the immune system: the impact of immunosenescence in aging. Maturitas 147: 7-13

Clark, W. 1991: The twin block technique. Functional Orthodontist 8(1): 24-25; 27-28

Clark, W. 1990: The twin block technique. Functional Orthodontist 7(4): 24-28; 31

Muñoz-Garcia, J.; Cochonneau, D.; Télétchéa, S.ép.; Moranton, E.; Lanoe, D.; Brion, R.ég.; Lézot, F.éd.ér.; Heymann, M.-F.ço.; Heymann, D. 2021: The twin cytokines interleukin-34 and CSF-1: masterful conductors of macrophage homeostasis. Theranostics 11(4): 1568-1593

Naughton, L.; Padeiro, M.; Santana, P. 2021: The twin faces of ageism, glorification and abjection: a content analysis of age advocacy in the midst of the COVID-19 pandemic. Journal of Aging Studies 57: 100938

Fraser, J.D. 2021: The twin origins of renormalization group concepts. Studies in History and Philosophy of Science 89: 114-128

Griffin, R.; Sustar, A.; Bonvin, M.; Binari, R.; del Valle Rodriguez, A.; Hohl, A.M.; Bateman, J.R.; Villalta, C.; Heffern, E.; Grunwald, D.; Bakal, C.; Desplan, C.; Schubiger, G.; Wu, C-ting.; Perrimon, N. 2009: The twin spot generator for differential Drosophila lineage analysis. Nature Methods 6(8): 600-602

Korányi, G.; Kovács, J. 1974: The twin transfusion syndrome. Orvosi Hetilap 115(42): 2484-2486

Palmer, T.; Berks, B.C. 2012: The twin-arginine translocation (Tat) protein export pathway. Nature Reviews. Microbiology 10(7): 483-496

Pajer, P.; Pecenka, Vír.; Karafiát, Vít.; Králová, J.; Horejsí, Z.; Dvorák, M. 2003: The twist gene is a common target of retroviral integration and transcriptional deregulation in experimental nephroblastoma. Oncogene 22(5): 665-673

Courty, L. 1948: The twist of the great epiploon. Journal des Sciences Medicales de Lille 66(19): 431

Courty, L. 1948: The twist of the great epiploon. Concours Medical 70(41): 2001

Siciliano, G. 1949: The twist of the healthy or ill trumpet in the puerperal state; a case of tubal cyst torsion in the 7th month of pregnancy. La Clinica Ostetrica e Ginecologica 51(1): 1-17

Stefanelli, S. 1947: The twist of the outbuildings. Rivista di Ostetricia e Ginecologia: 26-29(5): 256-262

Parisio, B. 1948: The twist of the uterine appendages in the framework of the acute abdomen. La Clinica Ostetrica e Ginecologica 50(1-2): 1-19

Tombola, F.; Pathak, M.M.; Gorostiza, P.; Isacoff, E.Y. 2007: The twisted ion-permeation pathway of a resting voltage-sensing domain. Nature 445(7127): 546-549

Szaro, P.ł; Witkowski, G.; Ciszek, B. 2021: The twisted structure of the fetal calcaneal tendon is already visible in the second trimester. Surgical and Radiologic Anatomy: Sra 43(7): 1075-1082

Posimreddy, S.; Patel, B.; Patel, R.; Patel, B.; Guragai, N.; Shamoon, F.; Joshi, M. 2020: The twisted truth: a case of suspected left coronary from right sinus and right coronary from left sinus. Acta Cardiologica 2020: 1-2

Dufour, A. 1949: The twisting of the spermatic cord. L' Hopital 37(576): 149

MacKenzie, L.E.; Stachelek, P. 2021: The twists and turns of chiral chemistry. Nature Chemistry 13(6): 521-522

Mohammadi, D. 2017: The twists and turns of colorectal cancer screening. LANCET. Gastroenterology and Hepatology 2(1): 10-11

Ashley, D.J. 1969: The two "hit" and multiple "hit" theories of carcinogenesis. British Journal of Cancer 23(2): 313-328

Arama, E.; Bader, M.; Srivastava, M.; Bergmann, A.; Steller, H. 2006: The two Drosophila cytochrome C proteins can function in both respiration and caspase activation. EMBO Journal 25(1): 232-243

Bode, C.J.; Gupta, M.L.; Suprenant, K.A.; Himes, R.H. 2003: The two alpha-tubulin isotypes in budding yeast have opposing effects on microtubule dynamics in vitro. Embo Reports 4(1): 94-99

Buzas, A.; Reichstein, T. 1948: The two available through degradation of strophanthidine, 3 beta, 5,14-trioxy-14-iso-21-norpregnan-19,20-diacids, isomeric at C-17; Glycosides and aglycons. Helvetica Chimica Acta 31(1): 84-90

Possenti, V.; Minardi, V.; Contoli, B.; Gallo, R.; Lana, S.; Bertozzi, N.; Campostrini, S.; Carrozzi, G.; Cristofori, M.; D'Argenzio, A.; De Luca, A.; Fateh-Moghadam, P.; Ramigni, M.; Trinito, M.O.; Vasselli, S.; Masocco, M. 2021: The two behavioural risk factor surveillances on the adult and elderly populations as information systems for leveraging data on health-related sustainable development goals in Italy. International Journal of Medical Informatics 152: 104443

Graves, J.W. 2007: The two best reasons NOT to focus on protein restriction in chronic kidney disease. Nature Clinical Practice. Nephrology 3(10): E1; Author Reply E2

Rasmussen, T.; Jensen, R.Bugge.; Skovgaard, O. 2007: The two chromosomes of Vibrio cholerae are initiated at different time points in the cell cycle. EMBO Journal 26(13): 3124-3131

Shearman, J.R.; Sonthirod, C.; Naktang, C.; Pootakham, W.; Yoocha, T.; Sangsrakru, D.; Jomchai, N.; Tragoonrung, S.; Tangphatsornruang, S. 2016: The two chromosomes of the mitochondrial genome of a sugarcane cultivar: assembly and recombination analysis using long PacBio reads. Scientific Reports 6: 31533

Spielmann, J.; Ahmadi, H.; Scheepers, M.; Weber, M.; Nitsche, S.; Carnol, M.; Bosman, B.; Kroymann, J.; Motte, P.; Clemens, S.; Hanikenne, M. 2020: The two copies of the zinc and cadmium ZIP6 transporter of Arabidopsis halleri have distinct effects on cadmium tolerance. Plant Cell and Environment 43(9): 2143-2157

Nair, R. 2005: The two cultures revisited. Indian Journal of Physiology and Pharmacology 49(3): 253-256

Gómez-Redondo, M.; Delgado, S.; Núñez-Franco, R.; Jiménez-Osés, G.; Ardá, A.; Jiménez-Barbero, J.ús.; Gimeno, A. 2021: The two domains of human galectin-8 bind sialyl- and fucose-containing oligosaccharides in an independent manner. a 3D view by using NMR. Rsc Chemical Biology 2(3): 932-941

Cesari, M.; Vanacore, N.; Agostoni, C. 2019: The two extremes meet: pediatricians, geriatricians and the life-course approach. Pediatric Research 86(4): 432-435

Johnson, R.; Halder, G. 2014: The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nature Reviews. Drug Discovery 13(1): 63-79

Lin, R.; Yan, T.; Luo, M. 2019: The two faces of PVN CRF neurons. Nature Neuroscience 22(4): 508-510

Mourigal, M. 2018: The two faces of a magnetic honeycomb. Nature 554(7692): 307-308

Mourigal, M. 2018: The two faces of a magnetic honeycomb. Nature 554(7692): 307-308

Yu, K-Da.; Shao, Z-Ming. 2011: The two faces of autophagy and the pathological underestimation of DCIS. Nature Reviews. Cancer 11(8): 618; Author Reply 618

Rao, C.N.R. 2011: The two faces of chemistry in the developing world. Nature Chemistry 3(9): 678-680

Scotto di Carlo, F.; Whyte, M.P.; Gianfrancesco, F. 2020: The two faces of giant cell tumor of bone. Cancer Letters 489: 1-8

Ball, P. 2021: The two faces of molten phosphorus. Nature Materials 20(10): 1304

Grob, T.J.; Fey, M.F.; Tobler, A. 2002: The two faces of p73. Cell Death and Differentiation 9(3): 229-230

Nitschke, J.R. 2011: The two faces of phosphorus. Nature Chemistry 3(1): 90

Winklhofer, K.F.; Tatzelt, Jörg.; Haass, C. 2008: The two faces of protein misfolding: gain- and loss-of-function in neurodegenerative diseases. EMBO Journal 27(2): 336-349

Latif-Hernandez, A.; Sabanov, V.; Ahmed, T.; Craessaerts, K.; Saito, T.; Saido, T.; Balschun, D. 2020: The two faces of synaptic failure in AppNL-G-F knock-in mice. Alzheimer's Research and Therapy 12(1): 100

Licari, E.; Sánchez-Del-Campo, L.; Falletta, P. 2021: The two faces of the Integrated Stress Response in cancer progression and therapeutic strategies. International Journal of Biochemistry and Cell Biology 139: 106059

Galli, S.J.; Wershil, B.K. 1996: The two faces of the mast cell. Nature 381(6577): 21-22

Bellanger, J.M.; Lazaro, J.B.; Diriong, S.; Fernandez, A.; Lamb, N.; Debant, A. 1998: The two guanine nucleotide exchange factor domains of Trio link the Rac1 and the RhoA pathways in vivo. Oncogene 16(2): 147-152

Gottwald, S.; Braun, D.A. 2020: The two kinds of free energy and the Bayesian revolution. Plos Computational Biology 16(12): E1008420

Lynaugh, J.E.; Bates, B. 1973: The two languages of nursing and medicine. American Journal of Nursing 73(1): 66-69

Lynaugh, J.E.; Bates, B. 1974: The two languages of nursing and medicine. Professioni Infermieristiche 27(2): 45-50

Yanai, I.; Lercher, M. 2020: The two languages of science. Genome Biology 21(1): 147

Törrönen, A.; Mach, R.L.; Messner, R.; Gonzalez, R.; Kalkkinen, N.; Harkki, A.; Kubicek, C.P. 1992: The two major xylanases from Trichoderma reesei: characterization of both enzymes and genes. Bio/Technology 10(11): 1461-1465

Ell, S.R. 1981: The two medicines: some ecclesiastical concepts of disease and the physician in the high Middle Ages. Janus; Revue Internationale de l'Histoire des Sciences de la Medecine de la Pharmacie et de la Technique 68(1-3): 15-25

Houben, E.N.G.; ten Hagen-Jongman, C.M.; Brunner, J.; Oudega, B.; Luirink, J. 2004: The two membrane segments of leader peptidase partition one by one into the lipid bilayer via a Sec/YidC interface. Embo Reports 5(10): 970-975

Boivin, A. 1948: The two nuclear acids and their role in the constitution and in the life of bacterial cells. Revue Canadienne de Biologie 7(3): 368-385

Petito, C.K.; Morgello, S.; Felix, J.C.; Lesser, M.L. 1990: The two patterns of reactive astrocytosis in postischemic rat brain. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 10(6): 850-859

Zhuravlev, A.Yu.; Wood, R.A. 2018: The two phases of the Cambrian Explosion. Scientific Reports 8(1): 16656

Miodini, P.; Fioravanti, L.; Di Fronzo, G.; Cappelletti, V. 1999: The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. British Journal of Cancer 80(8): 1150-1155

Zuo, K.; Marjault, H.-B.; Bren, K.L.; Rossetti, G.; Nechushtai, R.; Carloni, P. 2021: The two redox states of the human NEET proteins' [2Fe-2S] clusters. Journal of Biological Inorganic Chemistry: Jbic: a Publication of the Society of Biological Inorganic Chemistry 26(7): 763-774

Sulkunen, P. 2018: The two sides of public health. Nordisk Alkohol- and Narkotikatidskrift: Nat 35(2): 91-92

Karakulak, U.ğu.N.; Özer, N. 2021: The two sides of the spectrum: Paravalvular mitral regurgitation. Anatolian Journal of Cardiology 25(6): E26-E27

Dellovade, T.L.; Chan, J.; Vennstrom, B.; Forrest, D.; Pfaff, D.W. 2000: The two thyroid hormone receptor genes have opposite effects on estrogen-stimulated sex behaviors. Nature Neuroscience 3(5): 472-475

Gourley, D.G.; Shrive, A.K.; Polikarpov, I.; Krell, T.; Coggins, J.R.; Hawkins, A.R.; Isaacs, N.W.; Sawyer, L. 1999: The two types of 3-dehydroquinase have distinct structures but catalyze the same overall reaction. Nature Structural Biology 6(6): 521-525

Greer, E.N.; Hinton, J.J.C. 1950: The two types of wheat endosperm. Nature 165(4202): 746-748

Mathé, G.; Gerard-Marchant, R.; Texier, J.L.; Schlumberger, J.R.; Berumen, L.; Paintrand, M. 1970: The two varieties of lymphoid tissue "reticulosarcomas", histiocytic and histioblastic types. British Journal of Cancer 24(4): 687-695

Chen, S.; Cai, M.; Bao, Y. 2020: The two- to three-second time window of shot durations in movies. Psych Journal 9(4): 516-518

Przedborski, S. 2017: The two-century journey of Parkinson disease research. Nature Reviews. Neuroscience 18(4): 251-259

Machin, R. 2022: The two-child limit for benefits in the Supreme Court: implications for public health. Perspectives in Public Health 142(3): 137-138

Dong, Y-Hu.; Zhang, X-Fen.; Soo, H-Meng.Linda.; Greenberg, E.P.; Zhang, L-Hui. 2005: The two-component response regulator PprB modulates quorum-sensing signal production and global gene expression in Pseudomonas aeruginosa. Molecular Microbiology 56(5): 1287-1301

Liao, B.; Ye, X.; Chen, X.; Zhou, Y.; Cheng, L.; Zhou, X.; Ren, B. 2021: The two-component signal transduction system and its regulation in Candida albicans. Virulence 12(1): 1884-1899

Lasagni Vitar, R.M.; Rama, P.; Ferrari, G. 2022: The two-faced effects of nerves and neuropeptides in corneal diseases. Progress in Retinal and Eye Research 86: 100974

Yamada, M.; Chen, L-J.; Yoo, J.; Wang, S.; Fox, W.; Jara-Almonte, J.; Ji, H.; Daughton, W.; Le, A.; Burch, J.; Giles, B.; Hesse, M.; Moore, T.; Torbert, R. 2018: The two-fluid dynamics and energetics of the asymmetric magnetic reconnection in laboratory and space plasmas. Nature Communications 9(1): 5223

Castonguay, J.; Orth, J.H.C.; Müller, T.; Sleman, F.; Grimm, C.; Wahl-Schott, C.; Biel, M.; Mallmann, R.Theodor.; Bildl, W.; Schulte, U.; Klugbauer, N. 2017: The two-pore channel TPC1 is required for efficient protein processing through early and recycling endosomes. Scientific Reports 7(1): 10038

Raju, S.; Walker, W.; Noel, C.; Kuykendall, R.; Jayaraj, A. 2020: The two-segment caliber method of diagnosing iliac vein stenosis on routine computed tomography with contrast enhancement. Journal of Vascular Surgery. Venous and Lymphatic Disorders 8(6): 970-977

Song, W.; Mao, H.; Han, X. 2021: The two-sided effects of foreign direct investment on carbon emissions performance in China. Science of the Total Environment 791: 148331

Devitt, J.E. 1982: The two-step management of breast cancer. Canadian Journal of Surgery. Journal Canadien de Chirurgie 25(5): 475-476

Liggett, S.B. 2004: The two-timing thyroid. Nature Medicine 10(6): 582-583

Gibb, B.C. 2011: The two-week sabbatical. Nature Chemistry 3(7): 495-496

Roy, S.; Anjum, K. 2018: The two-week wait - a qualitative analysis of suspected head and neck cancer referrals. British Dental Journal 225(2): 159-163

Singh, P.; Warnakulasuriya, S. 2006: The two-week wait cancer initiative on oral cancer; the predictive value of urgent referrals to an oral medicine unit. British Dental Journal 201(11): 717

Nieves-Bonilla, J.M.; Kiaf, B.; Schuster, C.; Kissler, S. 2020: The type 1 diabetes candidate gene Dexi does not affect disease risk in the nonobese diabetic mouse model. Genes and Immunity 21(1): 71-77

Bonser, L.R.; Eckalbar, W.L.; Rodriguez, L.; Shen, J.; Koh, K.D.; Zlock, L.T.; Christenson, S.; Woodruff, P.G.; Finkbeiner, W.E.; Erle, D.J. 2021: The type 2 asthma mediator IL-13 inhibits SARS-CoV-2 infection of bronchial epithelium. Biorxiv: the Preprint Server for Biology 2021

Carrat, G.R.; Haythorne, E.; Tomas, A.; Haataja, L.; Müller, A.; Arvan, P.; Piunti, A.; Cheng, K.; Huang, M.; Pullen, T.J.; Georgiadou, E.; Stylianides, T.; Amirruddin, N.S.; Salem, V.; Distaso, W.; Cakebread, A.; Heesom, K.J.; Lewis, P.A.; Hodson, D.J.; Briant, L.J.; Fung, A.C.H.; Sessions, R.B.; Alpy, F.; Kong, A.P.S.; Benke, P.I.; Torta, F.; Teo, A.K.K.; Leclerc, I.; Solimena, M.; Wigley, D.B.; Rutter, G.A. 2020: The type 2 diabetes gene product STARD10 is a phosphoinositide-binding protein that controls insulin secretory granule biogenesis. Molecular Metabolism 40: 101015

Mellado-Gil, J.M.; Fuente-Martín, E.; Lorenzo, P.I.; Cobo-Vuilleumier, N.; López-Noriega, L.; Martín-Montalvo, A.; Gómez, I.de.Gracia.Herrera.; Ceballos-Chávez, M.; Gómez-Jaramillo, L.; Campos-Caro, A.; Romero-Zerbo, S.Y.; Rodríguez-Comas, Júlia.; Servitja, J-Marc.; Rojo-Martinez, G.; Hmadcha, A.; Soria, B.; Bugliani, M.; Marchetti, P.; Bérmudez-Silva, F.J.; Reyes, J.C.; Aguilar-Diosdado, M.; Gauthier, B.R. 2018: The type 2 diabetes-associated HMG20A gene is mandatory for islet beta cell functional maturity. Cell Death and Disease 9(3): 279

Bello-Chavolla, O.Y.; Aguilar-Salinas, C.A.; Avila-Funes, J.é A. 2020: The type 2 diabetes-specific dementia risk score (DSDRS) is associated with frailty, cognitive and functional status amongst Mexican community-dwelling older adults. Bmc Geriatrics 20(1): 363

Zhou, K.; Zhou, Y.; Yang, D.; Chen, T.; Liu, X.; Li, S.; Wang, Z. 2021: The type 3 adenylyl cyclase is crucial for intestinal mucosal neural network in the gut lamina propria. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 33(9): E14140

Russo, B.C.; Duncan-Lowey, J.K.; Chen, P.; Goldberg, M.B. 2021: The type 3 secretion system requires actin polymerization to open translocon pores. Plos Pathogens 17(9): E1009932

Robson, A. 2020: The type I IFN response to cardiac injury begins in the bone marrow. Nature Reviews. Cardiology 17(12): 758

Sorrentino, A.; Thakur, N.; Grimsby, S.; Marcusson, A.; von Bulow, V.; Schuster, N.; Zhang, S.; Heldin, C-Henrik.; Landström, Méne. 2008: The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nature Cell Biology 10(10): 1199-1207

Kang, J.Seok.; Saunier, E.F.; Akhurst, R.J.; Derynck, R. 2008: The type I TGF-beta receptor is covalently modified and regulated by sumoylation. Nature Cell Biology 10(6): 654-664

Sachdev, D.; Zhang, X.; Matise, I.; Gaillard-Kelly, M.; Yee, D. 2010: The type I insulin-like growth factor receptor regulates cancer metastasis independently of primary tumor growth by promoting invasion and survival. Oncogene 29(2): 251-262

Lee, J.Seok.; Shin, E-Cheol. 2020: The type I interferon response in COVID-19: implications for treatment. Nature Reviews. Immunology 20(10): 585-586

Zein-Sabatto, H.; Cole, T.; Hoang, H.D.; Tiwary, E.; Chang, C.; Miller, M.A. 2021: The type Ii integral ER membrane protein VAP-B homolog in C. elegans is cleaved to release the N-terminal MSP domain to signal non-cell-autonomously. Developmental Biology 470: 10-20

Chen, L.; Zhang, L.; Mei, X.; Wang, C.; Guo, Z.; Li, L.; Li, B.; Liang, Y.; Zou, S.; Dong, H. 2020: The type Ii phosphoinositide 4-kinase FgLsb6 is important for the development and virulence of Fusarium graminearum. Fungal Genetics and Biology: Fg and B 144: 103443

Forest, K.T. 2008: The type II secretion arrowhead: the structure of GspI-GspJ-GspK. Nature Structural and Molecular Biology 15(5): 428-430

Korotkov, K.V.; Sandkvist, M.; Hol, W.G.J. 2012: The type II secretion system: biogenesis, molecular architecture and mechanism. Nature Reviews. Microbiology 10(5): 336-351

Cornelis, G.R. 2006: The type III secretion injectisome. Nature Reviews. Microbiology 4(11): 811-825

Chatterjee, S.; Lekmeechai, S.; Constantinou, N.; Grzybowska, E.A.; Kozik, Z.; Choudhary, J.S.; Berger, C.N.; Frankel, G.; Clements, A. 2021: The type IIi secretion system effector EspO of enterohaemorrhagic Escherichia coli inhibits apoptosis through an interaction with HAX-1. Cellular Microbiology 23(9): E13366

Hauser, A.R. 2009: The type III secretion system of Pseudomonas aeruginosa: infection by injection. Nature Reviews. Microbiology 7(9): 654-665

Dong, X-Ping.; Cheng, X.; Mills, E.; Delling, M.; Wang, F.; Kurz, T.; Xu, H. 2008: The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel. Nature 455(7215): 992-996

Black, W.P.; Wang, L.; Jing, X.; Saldaña, R.Castañeda.; Li, F.; Scharf, B.E.; Schubot, F.D.; Yang, Z. 2017: The type IV pilus assembly ATPase PilB functions as a signaling protein to regulate exopolysaccharide production in Myxococcus xanthus. Scientific Reports 7(1): 7263

Howell, D.Andrew.; Sullivan, M.; Nugent, P.E.; Ellis, R.S.; Conley, A.J.; Le Borgne, D.; Carlberg, R.G.; Guy, J.; Balam, D.; Basa, S.; Fouchez, D.; Hook, I.M.; Hsiao, E.Y.; Neill, J.D.; Pain, R.; Perrett, K.M.; Pritchet, C.J. 2006: The type Ia supernova SNLS-03D3bb from a super-Chandrasekhar-mass white dwarf star. Nature 443(7109): 308-311

Qiu, Y.; Hu, L.; Yang, W.; Yin, Z.; Zhou, D.; Yang, H.; Zhang, Y. 2020: The type Vi secretion system 2 of Vibrio parahaemolyticus is regulated by QsvR. Microbial Pathogenesis 149: 104579

Trunk, K.; Peltier, J.; Liu, Y-Chia.; Dill, B.D.; Walker, L.; Gow, N.A.R.; Stark, M.J.R.; Quinn, J.; Strahl, H.; Trost, M.; Coulthurst, S.J. 2018: The type VI secretion system deploys antifungal effectors against microbial competitors. Nature Microbiology 3(8): 920-931

Li, L.; Wang, Y-Nuo.; Jia, H-Bing.; Wang, P.; Dong, J-Fang.; Deng, J.; Lu, F-Min.; Zou, Q-Hua. 2019: The type VI secretion system protein AsaA in Acinetobacter baumannii is a periplasmic protein physically interacting with TssM and required for T6SS assembly. Scientific Reports 9(1): 9438

Vettiger, A.; Winter, J.; Lin, L.; Basler, M. 2017: The type VI secretion system sheath assembles at the end distal from the membrane anchor. Nature Communications 8: 16088

Filloux, A. 2009: The type VI secretion system: a tubular story. EMBO Journal 28(4): 309-310

Cascales, E. 2008: The type VI secretion toolkit. Embo Reports 9(8): 735-741

Cao, Z.; Casabona, M.Guillermina.; Kneuper, H.; Chalmers, J.D.; Palmer, T. 2016: The type VII secretion system of Staphylococcus aureus secretes a nuclease toxin that targets competitor bacteria. Nature Microbiology 2: 16183

Kengmo Tchoupa, A.; Watkins, K.E.; Jones, R.A.; Kuroki, Aès.; Alam, M.Tauqeer.; Perrier, S.; Chen, Y.; Unnikrishnan, M. 2020: The type VII secretion system protects Staphylococcus aureus against antimicrobial host fatty acids. Scientific Reports 10(1): 14838

Fava, F.; Gitau, R.; Griffin, B.A.; Gibson, G.R.; Tuohy, K.M.; Lovegrove, J.A. 2013: The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome 'at-risk' population. International Journal of Obesity 37(2): 216-223

Belkin, A.; Summerbell, R.C.; Krajden, S.; Scott, J. 2020: The type isolate of a rare Phaeoacremonium species as a cause of human eumycetoma. Medical Mycology Case Reports 30: 5-7

Nakai, K. 2006: The type of "disclosure" that we want. Seishin Shinkeigaku Zasshi 108(4): 403-404

Kaczmarek, A.; Wrońska, A.K.; Boguś, M.ła.I.; Kazek, M.; Gliniewicz, A.; Mikulak, E.; Matławska, M. 2021: The type of blood used to feed Aedes aegypti females affects their cuticular and internal free fatty acid (FFA) profiles. Plos one 16(4): E0251100

Reina-Gutiérrez, S.; Cavero-Redondo, I.án.; Martínez-Vizcaíno, V.; Núñez de Arenas-Arroyo, S.; López-Muñoz, P.ón.; Álvarez-Bueno, C.; Guzmán-Pavón, M.ía.J.é; Torres-Costoso, A. 2022: The type of exercise most beneficial for quality of life in people with multiple sclerosis: a network meta-analysis. Annals of Physical and Rehabilitation Medicine 65(3): 101578

Escalante, I.; Elias, D.O. 2021: The type of leg lost affects habitat use but not survival in a non-regenerating arthropod. Ecology and Evolution 11(15): 10672-10685

Lamlum, H.; Ilyas, M.; Rowan, A.; Clark, S.; Johnson, V.; Bell, J.; Frayling, I.; Efstathiou, J.; Pack, K.; Payne, S.; Roylance, R.; Gorman, P.; Sheer, D.; Neale, K.; Phillips, R.; Talbot, I.; Bodmer, W.; Tomlinson, I. 1999: The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis. Nature Medicine 5(9): 1071-1075

Du Preez, A.; Law, T.; Onorato, D.; Lim, Y.M.; Eiben, P.; Musaelyan, K.; Egeland, M.; Hye, A.; Zunszain, P.A.; Thuret, S.; Pariante, C.M.; Fernandes, C. 2020: The type of stress matters: repeated injection and permanent social isolation stress in male mice have a differential effect on anxiety- and depressive-like behaviours, and associated biological alterations. Translational Psychiatry 10(1): 325

Punzel, M.; Moore, K.A.; Lemischka, I.R.; Verfaillie, C.M. 1999: The type of stromal feeder used in limiting dilution assays influences frequency and maintenance assessment of human long-term culture initiating cells. Leukemia 13(1): 92-97

Frank, M.; Albuisson, J.; Ranque, B.; Golmard, L.; Mazzella, J-Michael.; Bal-Theoleyre, L.; Fauret, A-Laure.; Mirault, T.; Denarié, N.; Mousseaux, E.; Boutouyrie, P.; Fiessinger, J-Noël.; Emmerich, J.; Messas, E.; Jeunemaitre, X. 2015: The type of variants at the COL3A1 gene associates with the phenotype and severity of vascular Ehlers-Danlos syndrome. European Journal of Human Genetics: Ejhg 23(12): 1657-1664

Velhagen, K. 1948: The type of vascularization in the differential diagnosis and clinic of some corneal diseases. Klinische Monatsblatter für Augenheilkunde und für Augenarztliche Fortbildung 113(1): 28-36

Ishikawa, S.; Yamamura, R.; Hashimoto, N.; Okubo, R.; Sawagashira, R.; Ito, Y.M.; Sato, N.; Kusumi, I. 2021: The type rather than the daily dose or number of antipsychotics affects the incidence of hyperglycemic progression. ProgressinNeuro-PsychopharmacologyandBiologicalPsychiatry 2021: 110453

Figueroa, A. 2021: The type species of Bronchocela Kaup, 1827 and lectotype designations for Agama cristatella Kuhl, 1820 and Agama gutturosa Merrem, 1820 (Squamata: Iguania: Agamidae). Zootaxa 4980(2): 397400

Chen, S.; Lóssio, C.áu.F.; Verbeke, I.; Verduijn, J.; Parakhonskiy, B.; Van der Meeren, L.; Chen, P.; De Zaeytijd, J.; Skirtach, A.é G.; Van Damme, E.J.M. 2021: The type-1 ribosome-inactivating protein OsRIP1 triggers caspase-independent apoptotic-like death in Hela cells. Food and Chemical Toxicology: An International Journal Published for the British Industrial Biological Research Association 157: 112590

Hansen, S.T. 1987: The type-IIIC tibial fracture. Salvage or amputation. Journal of Bone and Joint Surgery. American Volume 69(6): 799-800

Ito, H.; Yamamoto, T.; Morita, S. 2019: The type-reproduction number of sexually transmitted infections through heterosexual and vertical transmission. Scientific Reports 9(1): 17408

Pot, W. 1946: The types and types of dysentery bacteria grown in Curacao. Nederlands Tijdschrift Voor Geneeskunde 90(24): 650-653

Galliard, H. 1947: The types of exogenous development of Strongyloïdes stercoralis: their transformation by experimental passages. Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 141(3-4): 102-105

Chiba, H.; Tsukiyama, H.; Liang, J-Yuan.; Wang, S-Ming.; Shen, Z-Yu.; Hsu, Y-Feng. 2020: The types of skippers described by Shu-Iti Murayama (Lepidoptera: Hesperiidae). Zootaxa 4801(2)

Pereyra Filho, M.J. 1947: The types of the Mycobacterium tuberculosis Koch and its culture in potato glyceropeptonate ovarian broth. Hoja Tisiologica 6(1): 15-20

Lopez Vallejo, J. 1948: The types of the tubercle bacillus and the action of the corresponding tuberculins. Medicina 28(554): 157-174

Loizaga, A.J.A. 1947: The typhoid antigen in the prophylaxis of typhoid fever. RevistadelaAsociacionMedicaArgentina 61(601-602): 144

Dahle, M.; Fog, J. 1949: The typhoid epidemic of the Snåsa winter in 1894. Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 69(19): 506-508

Dubreuil, G. 1949: The typhoid epidemics of oyster origin in 1943 and 1944, in Gironde. Journal de Medecine de Bordeaux et du Sud-Ouest 126(9): 430-433

Geubel, J.L. 1948: The typhoid fever in Ruanda. Annales de la Societe Belge de Medecine Tropicale 28(1): 21-27

Geubel, J.L. 1948: The typhoid fever in Ruanda. Bruxelles Medical 28(34): 1733

Sanchis-Monsonís, G.; Fanelli, A.; Martínez-Carrasco, C.; Tizzani, P. 2020: The typical cestodes of the red fox in eastern areas of the Iberian Peninsula have a grouped distribution. Veterinary Parasitology 283: 109168

Wang, J.; Tang, L.; Tang, J.; Chen, J.; Gong, X.; Qin, L.; Huang, J.; Deng, Y.; Liu, X.; Huang, W.; Li, M.; Hu, N. 2022: The typically developing pediatric foot - the data of the 1744 children in China. Foot and Ankle Surgery: Official Journal of the European Society of Foot and Ankle Surgeons 28(3): 347-353

Begaux, C.; Decock, G. 1957: The typo-retinal degeneration of myotonic dystrophy. Bibliotheca Ophthalmologica: Suppla Ad Ophthalmologica 12(47): 551-558

Bojanić, L.; Flynn, S.; Gianatsi, M.; Kapur, N.; Appleby, L.; Shaw, J. 2020: The typology of parricide and the role of mental illness: Data-driven approach. Aggressive Behavior 46(6): 516-522

Turner, L. 2003: The tyranny of 'genethics'. Nature Biotechnology 21(11): 1282

Schwartz, B. 2004: The tyranny of choice. Scientific American 290(4): 70-75

Regestein, Q.R. 1994: The tyranny of health. New England Journal of Medicine 331(24): 1661

Jasper, W.G. 1987: The tyranny of technology. Medical Journal of Australia 147(4): 209-210

Dorff, E.N. 1995: The tyranny of technology. Sh'ma: a Journal of Jewish Responsibility 25(495): 2-4

Petrou, P. 2021: The tyranny of the SW quadrant. Journal of Medical Economics 2021: 1

Sirvent, A.; Boureux, A.; Simon, V.; Leroy, C.; Roche, S. 2007: The tyrosine kinase Abl is required for Src-transforming activity in mouse fibroblasts and human breast cancer cells. Oncogene 26(52): 7313-7323

Huang, F.; Huang, W.; Briggs, J.; Chew, T.; Bai, Y.; Deol, S.; August, A. 2015: The tyrosine kinase Itk suppresses CD8+ memory T cell development in response to bacterial infection. Scientific Reports 5: 7688

Samraj, A.K.; Stroh, C.; Fischer, U.; Schulze-Osthoff, K. 2006: The tyrosine kinase Lck is a positive regulator of the mitochondrial apoptosis pathway by controlling Bak expression. Oncogene 25(2): 186-197

Belka, C.; Gruber, C.; Jendrossek, V.; Wesselborg, S.; Budach, W. 2003: The tyrosine kinase Lck is involved in regulation of mitochondrial apoptosis pathways. Oncogene 22(2): 176-185

Kirstein, J.; Dougan, D.A.; Gerth, U.; Hecker, M.; Turgay, Kürşad. 2007: The tyrosine kinase McsB is a regulated adaptor protein for ClpCP. EMBO Journal 26(8): 2061-2070

Lv, Y.; Deng, H.; Liu, Y.; Chang, K.; Du, H.; Zhou, P.; Mao, H.; Hu, C. 2021: The tyrosine kinase SRC of grass carp (Ctenopharyngodon idellus) up-regulates the expression of IFN i by activating TANK binding kinase 1. Developmental and Comparative Immunology 114: 103834

Wang, S.; Tsarouhas, V.; Xylourgidis, N.; Sabri, N.; Tiklová, Kína.; Nautiyal, N.; Gallio, M.; Samakovlis, C. 2009: The tyrosine kinase Stitcher activates Grainy head and epidermal wound healing in Drosophila. Nature Cell Biology 11(7): 890-895

Baudot, A.D.; Jeandel, P.Y.; Mouska, X.; Maurer, U.; Tartare-Deckert, S.; Raynaud, S.D.; Cassuto, J.P.; Ticchioni, M.; Deckert, M. 2009: The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression. Oncogene 28(37): 3261-3273

Liu, H.; Cui, Y.; Bai, Y.; Fang, Y.; Gao, T.; Wang, G.; Zhu, L.; Dong, Q.; Zhang, S.; Yao, Y.; Song, C.; Niu, X.; Jin, Y.; Li, P.; Cao, C.; Liu, X. 2021: The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation. Iscience 24(2): 102078

Gong, J.G.; Costanzo, A.; Yang, H.Q.; Melino, G.; Kaelin, W.G.; Levrero, M.; Wang, J.Y. 1999: The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature 399(6738): 806-809

Sandström, M.; Johansson, M.; Andersson, U.; Bergh, A.; Bergenheim, A.T.; Henriksson, R. 2004: The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model. British Journal of Cancer 91(6): 1174-1180

Vandyke, K.; Fitter, S.; Zannettino, A.C.W. 2011: The tyrosine kinase inhibitor dasatinib (SPRYCEL) inhibits chondrocyte activity and proliferation. Blood Cancer Journal 1(2): E2

Liu, C-Yu.; Huang, T-Ting.; Chu, P-Yi.; Huang, C-Teng.; Lee, C-Han.; Wang, W-Lun.; Lau, K-Yi.; Tsai, W-Chun.; Chao, T-I.; Su, J-Chen.; Chen, M-Huang.; Shiau, C-Wai.; Tseng, L-Ming.; Chen, K-Feng. 2017: The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells. Experimental and Molecular Medicine 49(8): E366

Belka, C.; Marini, P.; Lepple-Wienhues, A.; Budach, W.; Jekle, A.; Los, M.; Lang, F.; Schulze-Osthoff, K.; Gulbins, E.; Bamberg, M. 1999: The tyrosine kinase lck is required for CD95-independent caspase-8 activation and apoptosis in response to ionizing radiation. Oncogene 18(35): 4983-4992

Liu, P.; Aitken, K.; Kong, Y.Y.; Opavsky, M.A.; Martino, T.; Dawood, F.; Wen, W.H.; Kozieradzki, I.; Bachmaier, K.; Straus, D.; Mak, T.W.; Penninger, J.M. 2000: The tyrosine kinase p56lck is essential in coxsackievirus B3-mediated heart disease. Nature Medicine 6(4): 429-434

Capello, D.; Gaidano, G.; Gallicchio, M.; Gloghini, A.; Medico, E.; Vivenza, D.; Buonaiuto, D.; Fassone, L.; Avanzi, G.C.; Saglio, G.; Prat, M.; Carbone, A. 2000: The tyrosine kinase receptor met and its ligand HGF are co-expressed and functionally active in HHV-8 positive primary effusion lymphoma. Leukemia 14(2): 285-291

Wang, Y.; Hall, R.A.; Lee, M.; Kamgar-Parsi, A.; Bi, X.; Baudry, M. 2017: The tyrosine phosphatase PTPN13/FAP-1 links calpain-2, TBI and tau tyrosine phosphorylation. Scientific Reports 7(1): 11771

Salmond, R.J.; Brownlie, R.J.; Morrison, V.L.; Zamoyska, R. 2014: The tyrosine phosphatase PTPN22 discriminates weak self peptides from strong agonist TCR signals. Nature Immunology 15(9): 875-883

Iuliano, R.; Le Pera, I.; Cristofaro, C.; Baudi, F.; Arturi, F.; Pallante, P.; Martelli, M.Luisa.; Trapasso, F.; Chiariotti, L.; Fusco, A. 2004: The tyrosine phosphatase PTPRJ/DEP-1 genotype affects thyroid carcinogenesis. Oncogene 23(52): 8432-8438

Li, T.; Xie, J.; Yao, X.; Zhang, J.; Li, C.; Ren, D.; Li, L.; Xie, Q.; Shao, H.; Qin, A.; Ye, J. 2021: The tyrosine phosphatase SHP-2 dephosphorylated by ALV-J via its Env efficiently promotes ALV-J replication. Virulence 12(1): 1721-1731